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The avian embryo exhibits a range o f unique features which favour its suitability as a 
model for investigating polyunsaturated fatty acid (PUFA) metabolism and transport. 
Recent evidence has shown that metabolic remodelling o f yolk fatty acid moieties 
occur in the yolk complex, especially the transfer o f docosahexaenoic acid (DHA) 
from phospholipid (PL) fraction in the yolk to triacylglycerol (TG) fraction in the 
blood. Moreover a preferential disappearance o f yolk DHA associated with the 
phospholipid fraction specifically phosphatidylethanolamine, had been described at 
around day 12. A phospholipase A2 was found to be involved in this process 
coincident with an increase o f DHA within the free fatty acid fraction in the yolk. 
Fatty acid metabolism in the yolk sac membrane during embryonic development has 
been studied. The activities o f key regulatory enzymes o f acyl glycerolipid synthesis 
and oxidation were measured; carnitine palmitoyltransferase I, monoacylglycerol 
acyltransferase, glycerolphosphate acyltransferase and diacylglycerol acyltransferase. 
Maximal CPT I activity was found at day 12 and significantly declined to day 18. The 
MGAT activity remained constant throughout development suggesting that this 
pathway o f glycerolipid biosynthesis may provide a mechanism to selectively retain 
essential PUFAs during a period o f intense fatty acid oxidation. The measured 
activity o f microsomal GPAT was noticeably lower compared to MGAT, with peak 
activity at day 12. The presence o f DGAT activity completes the TG synthetic 
pathway which is released into the embryonic blood as part o f very low density 
lipoproteins (VLDL). Characterisation and analysis o f lipoprotein lipid in the blood at 
day 14 and day 22 extended the knowledge regarding the delivery system o f DHA in 
the avian embryo. The VLDL TG was hydrolysed by lipoprotein lipase with the 
accompanying uptake o f fatty acids into the adipose tissue. Hydrolysis o f TG 
containing DHA by LPL appeared to be less active towards other TG species 
resulting in an enrichment o f DHA in the TG o f resulting lipoproteins which would be 
cleared by the liver. The results suggest that the yolk sac membrane has an important 
role in the regulation of DHA delivery to the developing embryo. Moreover the 
supply of DHA to the neural tissues in the developing embryo appears to be co­
ordinated by both the adipose tissue and liver.
LITERATURE
REVIEW
INTRODUCTION
The chick embryo provides a very useful model for the study o f  fatty acid metabolism. 
Yolk lipids are the primary nutritive source supporting embryogenesis and the absence 
o f maternal and embryonic interactions means that the avian embryo is an essentially 
closed system except for exchange o f respiratory gases (C 0 2 and 0 2) and water. This 
system provides a useful tool for the investigation o f lipid transport and the 
metabolism of polyunsaturated fatty acids (PUFA) especially since significant amounts 
o f essential fatty acids such as docosahexaenoic acid (DHA) or arachidonic acid (AA) 
are present in the yolk.
Fatty acid metabolism in the developing chick embryo can be divided into two parts. 
Firstly, avian development between day 0 and day 12 is associated with a low 
mobilisation of the yolk lipids, described in detail in several articles (Romanoff, A.L. 
1960; Slack, J.M.W. 1991; Bellairs, R. 1992). In contrast the last ten days of 
embryogenesis is characterised by the mobilisation o f yolk lipid for energy and the 
transfer o f polyunsaturated fatty acid to the embryo (Noble, R.C. & Cocchi, M. 1990; 
Maldjian, A. 1996). This study aims to further our understanding o f fatty acid uptake, 
metabolism and transport in avian embryo during development.
1.1 EGGS COMPONENTS
1.1.1 Com position and  struc tu re  of the egg.
The nutrients required for the formation and growth o f the embryo, including lipids, 
protein, vitamins and trace elements, are pre-packaged in the egg by the time of 
laying. The average 60g newly laid egg can be divided into four parts: the shell (6g), 
the shell membranes and air space, albumen (34g) and the yolk (20g). The growth of 
the embryo depends on the exchange o f respiratory gases (C 0 2 and 0 2) and moisture
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through microscopic eggshell pores. The shell also provides a barrier which prevents 
microbial contamination o f the egg (Board, R.G. & Sparks, N.H.C. 1991) Moreover 
mobilisation o f calcium from the shell occurs to meet the needs o f the developing 
embryo, this is mediated by the chorioallantoic membrane (Tuan, R.S. 1987). On 
approach to hatching, the piping o f the shell by the chick is facilitated by the thinning 
o f the shell as a result o f this calcium mobilisation (Noble, R.C. & Tullet, S.G. 
1989b).
The albumen fraction consists essentially o f water and a small amount o f  solid matter 
4% (w/w) with a significant amount o f carbohydrate. Several proteins (at least 13 
have been identified) are present; the major one being ovalbumen (54 % o f the total, 
w/w). The albumen is ingested orally by the chick embryo from day 12 o f 
development, and represents a major nutritional protein resource for the embryo 
(Palmer, B.D. & Guillette Jr, L.J. 1991).
The yolk consists of a single massive cell called the oocyte. It is composed o f 50 % 
water and 50 % solids. Lipids are by far the principal components, making up about 
66 % (w/w) o f the dry matter, protein represents almost 33 % (Romanoff, A.L. 
1960). The yolk is essentially an emulsion o f large floating lipid droplets and dense 
proteineous granules. Following high speed centrifugation o f the yolk three distinct 
fractions are produced: 1/ A floating fat layer consisting o f triacylglycerol (TG)-rich 
lipoproteins: 2/ A pellet consisting o f dense granule fraction containing some
associated lipid: 3/ An infranatant containing water-soluble proteins. The majority o f 
these components are not synthesised by the ovary but are secreted into the 
bloodstream from the liver and deposited in the oocyte. More than 90% o f the total 
yolk lipids are synthesised by the adult liver as specialized type o f very low density 
lipoprotein (VLDL). The VLDL fraction provides 60 % o f the yolk solids, 22 % o f 
the protein. The VLDL particles are small and regular in size (30 nm) and contain 
two apoproteins, namely apoB (m.w. 500 kDa) and apo-VLDL II (homodimer, 
subunit m.w. 9.5 kDa). The granule fraction, also synthesised by the liver, contributes 
25 % o f the solids, 48 % o f the protein but only 7 % of the yolk lipids. The granules 
are formed from vitellogenin and consists o f two proteins: phosphovitin (m.w. 30
3
kDa) and lipovitellin (m.w. 340 kDa) products o f  proteolysis. The formation and the 
deposition o f these components in the oocyte (yolk) by the parent bird are well 
documented (Griffin, H.D., Perry, M.M. & Gilbert, A.B. 1984; Noble, R.C. & 
Cocchi, M. 1990; Burley, R.W., Evans, A.J. & Pearson 1993). Following uptake into 
the oocyte, the apoproteins are proteolytically modified: apoB is modified to
apovitellins III, IV, V and VI and apo-VLDL-II is converted to apovitellin I. On the 
other hand, the composition o f the oocyte lipids remains the same as that secreted by 
the maternal liver (Noble, R.C. & Cocchi, M. 1990; Griffin, H.D. 1992; Etches, R.J. 
1996). Within the oocyte, the endocytotic vesicles packed with yolk precursor 
particles undergo a series o f fusion to form large membrane bound yolk spheres. 
These consist of tightly packed VLDL particles (Griffin, H.D. et al. 1984; White,
H.B. 1991; Griffin, H.D. 1992; Stevens, L. 1996). The fatty acid compositions o f the 
TAG, PL and CE o f the yolk o f the domestic chicken egg are given in Table 1.
Table 1: Fatty  acids compositions of the lipids o f the initial yolk. The fatty  acids 
listed account for the m ajority  of the fatty  acids present. The rem aining small 
percentage consists of C 14 , C 15, C j7 and C2o acids (Noble, R .C . & Cocchi, M. 
1990).
CE TG PE PS PC Sph FC
wt. %  of total lipid 
Fatty  acids, wt. % of 
total
1.3 63.1 7.10 0.81 20.5 0.3 4.9
Palm itic 29.1 24.5 21.7 33.6 33.7 41.7
Palmitoleic 1.0 6.6 1.1 5.4 1.0 6.5
Stearic 9.5 6.4 30.1 27.3 15.8 17.6
Oleic 40.1 46.2 15.3 15.9 27.7 23.7
Linoleic 18.0 14.7 9.2 7.3 14.1 9.1
Linolenic 0.3 1.1 <0.5 <0.5 <0.5 <0.5
A rachidonic 0.9 0.3 13.2 8.5 4.4 <0.5
Docosahexaenoic 0.5 <0.5 8.4 1.2 1.8 <0.5
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By far, the principal lipid class is triacylglycerol (TG) followed by phospholipid (PL), 
and then free cholesterol. Cholesteryl ester (CE) and free fatty acids (FFA) are also 
present but are minor components. Phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) represents the majority o f the phospholipid in the 
yolk, about 70 % and 25 % respectively. Oleic acid (18:1 n-9) is found to be the 
major fatty acid in the CE, TG and total PL fractions. Palmitic (16:0) and stearic acid 
(18:0) together represent more than a third o f the fatty acids in each fraction. Linoleic 
acid (18:2n-6) is the major polyunsaturated fatty acids, whereas linolenic acid (18:3n- 
3) is present only at low concentrations, at least in eggs from hens maintained on 
current commercial diets. The C20-22 fatty acids, 20:4n-6 (arachidonic acid; AA) and 
22:6n-3 (docosahexaenoic acid; DHA) are found predominantly associated with the 
phospholipid fraction with only trace amounts o f these long chains PUFAs detectable 
in TAG and CE fraction. An extensive structural analysis has been performed on the 
triacylglycerol and phospholipid fractions o f the yolk (Noble, R.C. & Cocchi, M. 
1990) to establish the position and disposition o f the major fatty acids. A summary o f 
their findings is shown in Table 2.
Table 2: Stereospecific analysis of yolk triacylglycerol and phospholipid in the 
initial yolk (Noble, R.C. & Cocchi, M. 1990). — Not detected.
Triacylglycerol Phospholipid
PO SITIO N 1 2 3 1 2
Palm itic 71.5 5.1 6.5 71.8 2.0
Palmitoleic 6.0 2.6 5.7 — —
Stearic 4.1 1.4 8.7 18.1 0.5
Oleic 14.7 56.0 74.6 7.3 44.2
Linoleic 2.3 33.5 3.5 0.6 27.8
Linolenic 0.8 1.2 0.6 — 6.9
A rachidonic — — — - - 1.5
Docosahexaenoic _ _ _ _ 13.8
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The majority o f 20:4n-6 and 22:6n-3 are found in the PE fraction. As in most animal 
tissues, saturated fatty acid are predominantly associated in position 1, and 
unsaturated in position 2, the fatty acid 20:4n-6 and 22:6n-3 are attached in second 
position.
6
1.2 FATTY ACID M ETABOLISM  DURING EM BRYOGENESIS.
Once the egg has been laid and incubation initiated, embryonic development goes on 
within a closed system apart from the exchange o f heat, respiratory gases and water 
vapour. The nutrition o f the embryo during the early stages o f development is poorly 
understood, but it has been claimed that glucose and amino acids provide the main 
energy source at this time (Romanoff, A.L. 1967; Noble, R.C. & Cocchi, M. 1990). 
During the latter half o f development, which represents the major growth period, the 
energy metabolism o f the embryo is characterised by the utilisation o f yolk lipid.
The formation and the growth o f the embryo and the extra-embryonic organs are 
discussed in several articles (Romanoff, A.L. 1960; Slack, J.M.W. 1991; Bellairs, R. 
1992). The early stages o f development see the growth o f extraembryonic structures 
such as the amniotic, the chorioallantoic and the yolk sac membrane. The 
chorioallantoic structure is found inside the surface o f shell and consists o f a highly 
vascularised membrane. The blood flowing in the blood vessel picks up oxygen and 
delivers it to the developing embryo. Carbon dioxide is removed from the embryo 
and carried in the blood to the chorioallantoic membrane when it then diffuses 
through the eggs shell pores. The rates o f 0 2 uptake and C 0 2 release by the egg 
increase dramatically from about day 10, reaching a plateau level by day 18 o f 
incubation. This may reflect the increased rate o f p-oxidation o f yolk derived lipids 
by embryonic tissues (Romanoff, A.L. 1967; Noble, R.C. & Tullet, S.G. 1989b). The 
second major role o f this organ is the mobilisation o f the Ca2+ from the shell to supply 
the needs o f the embryo. This mechanism is based on the conversion o f C 0 2 to 
carbonic acid catalysed by carbonic anhydrase. This reaction and the transport o f 
calcium into the blood circulation involve the presence o f a chorioallantoic Ca2+ 
binding protein (Tuan, R.S. 1987).
The yolk sac membrane structure is formed from the dissolution o f the continuous and 
the extra vitellines membranes. The yolk sac membrane consists o f an outer 
mesoderm consisting of flattened cells to form a supportive membrane and an inner
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endoderm consisting o f simple columnar cells containing the usual range o f subcellular 
components and through which yolk absorption occurs (Romanoff, A.L. 1960). 
During the first week o f development, the embryo grows on the surface o f the yolk, at 
the same time the yolk sac membrane grows out to encapsulate the yolk which is 
complete by the fifth day.
The major role o f the yolk sac membrane is the uptake o f yolk materials and the 
transfer o f these components into the embryonic circulation. The absorptive side o f 
the membrane forms elaborate folds or villi which increases the membrane surface in 
contact with the yolk. At the same time, the yolk sac membrane undergoes extensive 
vascularization through the development o f a network o f capillaries emanating from 
within the villi. The blood flowing from these capillaries passes into the portal system 
o f the embryo by several major vitelline veins that enter the embryo through the yolk 
stalk. In some respects this membrane is analogous to the mammalian placenta and 
shares some characteristics with the small intestine.
1.2.1. Lipid uptake by the yolk sac membrane.
The transfer o f yolk lipid during the incubation period has been extensively studied in 
the chicken (Romanoff, A.L. 1960; Noble, R.C. & Moore, J.H. 1964; Noble, R.C. & 
Moore, J.H. 1967b; Maldjian, A. 1996). The mean weights o f total lipid associated 
with the yolk contents, yolk sac membrane and tissue o f the chick embryo at different 
stages of incubation are shown on the Figure 1.
The amount o f lipid transferred from the yolk during the first 13 days is minimal. 
From day 13 until hatching period, the lipid uptake increases dramatically. The 
amount of yolk lipid decreases from around 5 g at day 13 to 1 g at day 21 (hatching) 
i.e. an overall loss o f 400 mg per day. Between days 13 and days 17 o f incubation, 
the uptake o f lipids is accompanied by its rapid accumulation in the yolk sac 
membrane, such that by day 17 the membrane contains as much lipid as the yolk 
contents (Noble, R.C. & Moore, J.H. 1967b). From day 17 to hatching there is
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gradual loss of lipid from the membrane and an associated increase in lipid associated 
with the embryo (Noble, R.C. & Cocchi, M. 1990).
total lipid (g)
6
5
4
3 Embryo
2
yolk
1
Ysm
0
2113 17 190
days of development
Figure 1: The relative movement of lipid from the yolk contents into the chick 
embryo through the yolk sac membrane. Weights of total lipid in the yolk 
contents, yolk sac mem brane and embryonic tissues during the last week of 
incubation (Noble, R.C. & Cocchi, M. 1990).
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The proportions o f the major lipid classes o f the yolk complex during development 
are shown in Table 3 (Noble, R.C. & Cocchi, M. 1990). The proportions o f the 
major lipid classes o f the yolk remain approximately constant throughout 
development. However the PC/PE ratio increased from around 3 in the unincubated 
egg yolk to almost 9 at day 21 o f incubation.
Table 3: L ipid changes in the yolk during developm ent (Noble, R .C. & Cocchi, 
M. 1990).
Days o f  incubation 0
Yolk content 
13 21
Total lipid, g 6.11 4.93 0.80
Lipid composition, % o f total lipid
CE 1.3 0.42 0.50
Free cholesterol 4.9 6.11 5.00
TG 63.1 71.8 75.9
PL 29.7 21.4 18.2
Phospholipid composition, %
of total phospholipid
PE 23.9 14.0 8.30
PS 2.7 1.21 3.43
PC 69.1 75.4 71.7
sph 1.0 1.79 2.67
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This result has also been found previously where a preferential uptake o f the PE 
fraction, especially the molecular species o f PE that contains DHA, from the yolk 
occurred from around day 12 (Noble, R.C. & Moore, J.H. 1967b), see Table 4.
Table 4: Preferential uptake of PE and DHA from  yolk lipid (Noble, R.C. & 
M oore, J .H . 1967b).
Yolk day 0 Yolk day 15 Yolk day 19
PC PE PC  PE PC PE
wt % of total PL 69.1 23.9 80.6 14.2 80.8 12.4
Fatty acid (wt % of total lipid)
16:0 33.5 21.2 31.1 20.6 31.8 22.4
18:0 15.7 29.5 16.1 26.0 15.9 27.6
18:ln-9 27.5 15.0 28.0 20.5 27.9 19.3
18:2n-6 14.0 9.0 15.2 11.4 15.5 10.1
20:4n-6 4.3 12.9 4.6 11.7 4.8 12.3
22:6n-3 1.7 8.2 1.5 3.1 1.0 1.9
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The transfer of 16:0, 18:0, 18:1, 18:2, 18:3 and AA followed the same kinetic profile 
throughout development. In contrast, the transfer of DHA was shown to have a 
different profile. Suggesting that DHA is transported differently from other yolk 
lipids (Maldjian, A., Farkas, K , Noble, R.C., Cocchi, M. & Speake, B K. 1995). See 
Figure 2.
Transfer of fatty acids from the lipids of the yolk
complex
100 x
O
80
60
20 -
15 18 220 11 136
Docosahexanoic
acid 
■o— Palmitic acid
x Oleic acid
Days of development
Figure 2\ Transfer of fatty acids from the lipids of yolk complex. Changes in 
level of oleic acid (x), Palmitic acid (O) and DHA (■) are shown during 
incubation. Values are expressed as percentages of the amounts in the initial 
yolks before incubation and are the means of 4 replicates. (M aldjian, A. et al. 
19951.
There is no real evidence for extracellular digestion having a role in the uptake of the 
major lipids into the membrane. Nevertheless, low levels of lipid breakdown products
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were identified within the yolk during the most intense period o f lipid uptake. Free 
fatty acid, glycerol, lyso-phospholipid have been observed in the yolk (Rhodes, D.N. 
& Lea, C.H. 1957; Romanoff, A.L. 1960; Noble, R.C. & Cocchi, M. 1990). This 
suggests that there may be a lipase present which hydrolyses yolk lipid moieties.
The bulk transfer o f yolk lipid by the endodermal cells (apical surface) has been shown 
from electron microscopy studies to occur by a process o f phagocytosis. These 
studies have shown that lipid droplets are surrounded by the microvilli o f the yolk sac 
membrane and incorporated directly inside the cell. This process result in the 
accumulation o f large lipid droplets that often occupy the whole cytoplasmic space 
(Noble, R.C. & Cocchi, M. 1990). Electron microscopy studies have also provided 
important evidence that extensive modification o f the lipid droplet occurs in the yolk 
sac membrane, ultimately resulting in the formation o f lipoprotein particles that are 
secreted by exocytosis from the basal surface o f the endoderm cells. The presence o f 
lipid rich vesicles in the cistemae o f the reticulum endoplasmic and Golgi have been 
identified. The yolk sac membrane is well equipped for the assembly o f yolk derived 
lipids into lipoprotein for secretion into the blood stream (Lambson, R.O. 1970).
Previous work has demonstrated that the fatty acids that accumulate in the embryonic 
lipids are almost entirely derived from the yolk. It had been found that up to 80 % of 
the Ci6 and Cig fatty acids transferred from the beginning o f the incubation to the first 
day after hatching are oxidized for energy, indeed about 90% of the total energy 
requirements for embryogenesis is derived from the p-oxidation o f fatty acids. 
(Maldjian, A. et a l 1995).
Table 5 Recovery of yolk lipids of the newly hatched chick. The amount of each 
fatty acid present in total lipid per day-old chick is expressed as a percentage of 
the amount transferred from the initial yolk between the first day of 
embryogenesis and the first day post hatching. Taken from Maldjian (1996).
amount in lipids of day-old chicks 
as % of that transferred from yolk
16:0 20.5
18:0 26.5
18:ln-9 19.0
18:2n-6 25.3
20:4n-6 '■ 74.6
22:6n-3 60.6
DHA (22:6n-3) and arachidonic acid (20:4n-6) are not oxidized to the same extent as 
other fatty acids with 60.6 % and 74.6 %, o f the original yolk content being 
transferred to the chick respectively. Moreover other works have showed that the 
proportion o f DHA and AA are progressively increasing during transit from the yolk 
to the embryonic plasma (Yafei, R. & Noble, R.C. 1990).
The major source o f DHA in the yolk is phospholipid, whereby DHA comprises 
approximately 8% w/w o f total PE fatty acids. In contrast only trace levels (less than 
0.2 %) o f DHA are present in yolk triacylglycerol (Noble, R.C. & Cocchi, M. 1990). 
Analysis o f embryonic plasma, however, has shown that DHA is predominately 
associated with the TG fraction up to 11 % Table 6.
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Table 6: Changes in the fatty  acid compositions of triacylglycerol and 
phospholipid during  transfer between the yolk, the yolk sac m em brane and  the 
em bryonic plasm a. (Yafei, R. & Noble, R.C. 1990).
Yolk (day 0) YSM (day 12) Plasm a (day 12)
Lipid class TG PL TG PL TG PL
% w/w of total lipid 64.6 28.3 68.6 24.6 42.8 25.6
wt % of total lipid
16:0 24.6 27.0 27.7 24.5 25.6 32.7
18:0 6.0 16.8 6.3 18.5 8.0 15.8
18:ln-9 44.7 25.1 41.0 24.1 34.4 15.3
18:2n-6 15.3 15.2 16.1 15.4 10.9 13.9
20:4n-6 0.2 6.5 0.7 9.7 3.5 17.8
22:6n-3 0.2 5.7 1.3 4.5 11.5 3.1
Therefore, following uptake o f DHA from the yolk into the yolk sac membrane, and 
its subsequent secretion into the blood, DHA is transferred from the phospholipid 
moiety and incorporated into triacylglycerol, this TG is then presumably assembled 
into lipoprotein particles and secreted into the embryonic circulation The distribution 
o f arachidonic acid between the plasma lipid classes differs sharply from the pattern 
displayed by DHA. Although significant levels o f arachidonic acid are found in the 
plasma triacylglycerol, much higher proportions are present in the phospholipid 
fraction.
This pattern o f fatty acid redistribution is also a characteristic found in phospholipid 
and triacylglycerol o f chylomicron during absorption o f lipid by the mammalian 
intestine. Arachidonic acid is preferentially incorporated into chylomicron 
phospholipid (Nilson, A., Landin, B., Jensen, E. & Akesson, B. 1987; Nilson, A., 
Hjeltje, L. & Strandvik, B. 1992), whereas DHA and other n-3 polyunsaturated fatty 
acids exhibit a greater tendency for incorporation into chylomicron triacylglycerol (Li,
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J., Wetzel, M.G. & O'Brien, P.J. 1992). It should be noted however, that some 
embryonic fatty acids may be derived from de novo synthesis due to the presence o f a 
desaturation/elongation enzyme system. The presence o f the A6-desaturase in the 
yolk sac membrane and tissues o f the embryo may catalyse the conversion o f linoleic 
acid (18:2n-6) to arachidonic acid (20:4n-6) (Noble, R.C. & Cocchi, M. 1990). The 
de novo synthesis o f DHA does not appear to have an important role in the supply of 
this essential fatty due to the low availability o f linolenic acid (18:3n-3) the required 
substrate.
In summary, DHA is taken up preferentially from the yolk by the yolk sac membrane 
compared to the other fatty acids. The major proportion o f DHA is present as a 
component o f PE, and this phospholipid species disappears preferentially from the 
yolk. DHA is associated predominantly with the triacyglycerol fraction in the blood in 
contrast to th a t found in the yolk. Arachidonic acid, however is found to be 
associated with the plasma phospholipid fraction. DHA appears to be preserved in 
the developing embryo against a background o f high fatty acid oxidation. There 
therefore must exist a system or a mechanism whereby PUFAs are remodelled during 
transport across the yolk sac membrane, and are protected from fatty acid oxidation in 
the mitochondria.
1.2.2. Formation and release of plasma lipoprotein by the yolk sac membrane.
The principle o f lipoprotein formation has been studied using cell lines derived from 
the liver and the intestine o f adult mammals (Maria, C.L. 1991). In the chick embryo, 
the yolk sac membrane is responsible for the synthesis and release o f lipoproteins 
(Griffin, HD. 1992; Shand, J.H., West, D.W., Noble, R.C. & Speake, B.K. 1994). A 
direct link between the rapid conversion o f yolk-derived cholesterol to cholesteryl 
ester and ifc requirement for the assembly o f stable lipoprotein particles to enable lipid 
transfers tc the embryo have been strongly suggested (Shand, J.H. et al. 1994). 
Cholesteryl esters are formed by the presence, on the cytoplasmic face o f the 
endoplasmic reticulum (ER), o f acyl-CoA: cholesterol acyl-transferase (ACAT). This
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enzyme has been analysed and its activity quantified. Yolk sac membrane AC AT 
activity increased 4-fold between days 9 and 16 o f development which suggests that 
formation of lipoproteins maybe o f importance during this period. A major step o f 
lipoprotein assembly is the association o f nascent apoB with newly synthesised neutral 
lipid in the lumen o f the endoplasmic reticulum. ApoB is the major structural protein 
o f chylomicrons and VLDL (Converse, G. & Skinner, E.R. 1992). Synthesis o f apoB 
together with the synthesis o f TG and CE for lipoprotein assembly take place by the 
co-ordinated actions o f diacylglycerol acyl transferase (DGAT) and ACAT located on 
the cytoplasmic face o f the ER. The presence o f DGAT activity in the yolk sac 
membrane has not been determinated.
1.2.3. Delivery of plasm a lipids to the tissues. The role of lipoprotein lipase.
Lipids are transported in the blood associated with lipoprotein particles. Lipoproteins 
are classified according to increasing density: chylomicrons, chylomicron remnants, 
very low density lipoproteins (VLDL), intermediate-density lipoproteins (DDL), low 
density lipoproteins (LDL) and high density lipoproteins (HDL). Each o f these 
particles consists o f a core o f hydrophobic lipids surrounded by a shell o f polar lipids 
and apoproteins. Triacylglycerols and cholesterol are transported into the blood 
predominantly associated with the VLDL. Triacylglycerol in VLDL are processed by 
the action o f lipoprotein lipase (LPL, e.c. 3.1.1.34). This enzyme is present at the 
luminal surface o f the blood capillaries o f specific tissues where it catalyses the 
hydrolysis o f triacylglycerols present in the plasma VLDL. The fatty acids thus 
released can be taken up and used by the adjacent tissue (Maria, C.L. 1991). The 
presence of this enzyme in specific tissues of the developing chick was investigated 
previously (Speake, B.K., Noble, R.C. & McCartney, R.J. 1993) See Table 7. 
Lipoprotein lipase (LPL) was characterised by its sensitivity to inhibition by NaCl and 
its requirement for apoC-II. LPL activity was found to be highest in the adipose 
tissue. Moreover the activity was found at around day 14 o f incubation in parallel 
with the high rate o f transfer o f fatty acid from the yolk (Speake, B.K. et al. 1993; 
Maldjian, A. etal. 1995).
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Table 7: Lipase activity characteristics of chick's embryo at day 14 of incubation 
(Speake, B.K. et al. 1993).
Lipase activity (units/g tissue)
Standard assay +NaCl -apoC-II
Adipose tissue 87.4 3.4 7.1
Heart 30.2 2.5 2.1
Thigh muscle 5.8 2.1 2.0
Breast muscle 1.3 0.8 0.8
Liver 6.0 5.5 4.6
Brain 4.6 4.7 4.5
It has been suggested that the high activity of embryonic LPL in adipose tissue will 
favour the diversion of a significant proportion of the triacylglycerol-fatty acids into 
the adipocytes for storage. However the significant activity of LPL in the embryonic 
heart suggests an important role of fatty acids in energy provision in this tissue. It has 
been suggested that LPL may have a direct role in determining the composition of fatty 
acid taken up by the embryonic tissues, notably adipose tissue and liver (Speake, B.K. 
et al. 1993). Studies have indicated that TG species containing C20 and C22 PUFA 
exhibit a degree of resistance to LPL action (Nilson, A. et al. 1987; Melin, T., Qi, C., 
Bengtsson-Olivecrona, G., Akesson, B. & Nilsson, A. 1991). Free fatty acid release 
from plasma chylomicron TG by LPL action contained a lower proportion of C20 and 
C22 PUFA compared to the initial chylomicron TG. Moreover the residual TG was 
enriched in C20 and C22 PUFA. In the chick embryo, a significant amount of DHA 
was incorporated into adipose tissue in accordance with the high LPL activity 
(Speake, B.K. et al. 1993). However the residual TG was found to be enriched in 
DHA suggesting that TG species containing DHA are somewhat resistant to the action 
of LPL compared to other TG species. Following the hydrolysis of a large 
proportion of the lipoprotein TG by LPL, the resultant remnant particles, IDL, 
consisting mainly of CE can be taken up by the liver, or converted into LDL. LDL are
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the major carrier o f cholesterol in the blood, they contain a single copy o f apoB, 
which is recognised by target cells. LDL is known to have several roles: transport of 
cholesterol to periphery and regulation o f the cholesterol metabolism. HDL particles 
are derived from surplus surface material (phospholipids, free cholesterol and 
apoproteins) o f triacylglycerides-rich lipoproteins during lipolysis as described above. 
However it is incorrect to regard HDL as a single homogeneous species, since it is 
known to be a mixture o f particles that differ in size, in lipid and apolipoprotein 
composition.
1.2.4. The role of the adipose tissue
It has been suggested that adipose tissue may play a pivotal role in the delivery of 
DHA to the developing tissues (Maldjian, A. 1996). DHA is associated with the 
triacylglycerol fraction o f plasma lipoproteins and will therefore be susceptible to 
hydrolysis by LPL. Adipose tissue has a very high LPL activity and although it may 
prefer other TG species, LPL will exhibit some activity towards DHA containing TG 
thereby supplying adipose tissue with this fatty acid. Analysis o f the fatty acid 
composition o f adipose tissue in the developing avian embryo (Maldjian, A. 1996) 
showed that the amounts o f the major Cis fatty acids in the tissue TG changed in 
parallel with the profile o f TG accumulation in the depot, with a continuous increase 
between days 12 and 19, then remaining constant over the hatching period. However 
a totally different pattern o f accumulation was found for DHA. The amount o f DHA 
found in the TG increased to day 16, and plateaued and then decreased dramatically 
over the hatching period. See Figure 3.
Moreover studies looking at the release o f polyunsaturated fatty acid from adipose 
TG both in vivo and in vitro, have shown that C20-22 polyunsaturated fatty acids are 
preferentially mobilised from the adipose tissue and released into the circulation as 
free fatty acids (Speake, B.K., Cerolini, S., Maldjian, A. & Noble, R.C. 1997) over 
the hatching period.
19
Amount of 
DHA and 4  
AA
(mg/depot) 3
2
1
0
10 13 16 19 22
Days of development
140
120
100
80
60
40
20
0
Amounts 
of oleic acid
(mg/depot)
22:6 n-3 
20:4 n- 6  
18:1 n-9
Figure 3; Amounts of DHA (▲), arachidonic acid (0) and oleic acid (■) in 
adipose triacylglycerol, the amounts (mg/depot) are shown. S.E.M. were always
less than 10 % , comparison between days 22 and 19: aP<0.001, CP<0.02,
(Farkas, K., Ratchford, I.A.J., Noble, R.C. & Speake, B.K. 1996).
1.2.5. The role of the liver.
During the latter half of avian development, the liver is being supplied with lipoprotein 
remnants which consist largely of CE. Analysis of the lipid composition of the liver 
during avian development was done previously (Noble, R.C. & Moore, J.H. 1967a: 
Noble, R.C. & Cocchi, M. 1990; Shand, J.H. et al 1994; Maldjian, A. 1996) See 
Table 8. The lipid composition of the liver bears no resemblance to that of the lipid 
absorbed from the yolk. The yolk lipid consists in the main of TG (70-75%), PL (20- 
25%) and free cholesterol (6-7%), whereas the accumulation of lipid in the liver
20
during the last week of development is almost wholly accounted for by cholesteryl 
ester. (Noble, R.C. & Moore, J.H. 1967a; Shand, J.H. etal. 1994).
Table 8: L ipid and fatty acid com position change in the liver du ring  last week of 
incubation (Noble, R.C. & Cocchi, M . 1990).
CE TG PL
day of incubation 13 21 13 21 13 21
Lipid concentration (mg/liver) 
F a tty  acid composition
(%, w/w o f total lipid)
1.63 80.2 15.1 3.58 51.4 14.2
16:0 2.31 1.95 23.4 23.0 22.4 17.8
18:0 2.04 2.74 8.81 11.1 24.6 28.4
18:ln -9 77.2 79.6 30.4 35.7 7.29 7.97
18:2n-6 12.7 12.5 8.32 8.23 9.94 13.8
20:4n-6 2.24 1.47 3.52 2.92 26.2 20.0
22:6n-3 1.91 0.42 20.1 11.6 6.45 9.12
Previous work has showed that there is a transfer o f DHA from TG to PL in the liver 
and this transfer appeared to be specific for DHA and is not exhibited by other fatty 
acids (Noble, R.C. & Cocchi, M. 1990; Maldjian, A. 1996). In some studies done on 
neonatal rodents, it was suggested that the liver may have a major role in the 
mediation o f DHA transport to the brain and retina (Li, J. et a l 1992). The unique 
profile o f DHA metabolism in the developing avian embryo suggests that the avian 
liver may also be an important regulator o f this essential PUFA delivery.
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1.2.6. Delivery of DHA into the brain .
The essential role o f dietary n-3 fatty acid in the development o f the brain and retina is 
well documented (Neuringer, M., Anderson, G.J. & Connor, W.E. 1988; Anderson, 
G.J., Connor, W.E. & Corliss, J.D. 1990; Makrides, M., Neumann, M., Simmer, K., 
Pater, J. & Gibson, R. 1995). DHA is a major PUFA in the brain and retina and 
deficiencies o f this fatty acid in the diet lead to disturbances in behaviour, reduced IQ 
in human infants and impaired visual acuity. Very high levels o f DHA are present in 
the photoreceptor cells o f the retina and in the brain (the retinal membranes have a 
high content o f phospholipid with DHA comprising up to 65 % o f the total fatty acids 
o f PE and PS). In the chick embryo similar results were found in the brain by 
Maldjian et al (1996) See Table 9.
Table 9: The fatty  acid profiles of the m ajo r PL classes of brains from  day 14 
chicken embryos (M aldjian, A. et <z£l996).
PC PE PS P I
w t %  of total PL
Fatty acid (wt % of total lipid)
40.8 34.6 19.5 5.4
16:0 61.4 13.5 10.1 3.5
18:0 3.8 21.4 37.4 37.6
18:ln-9 23.8 9.0 7.0 9.0
18:2n-6 2.6 0.9 1.4 0.6
18:3n-3 0.2 0.2 0.2 —
20:4n-6 3.0 13.0 3.2 45.0
22:6n-3 4.1 40.5 39.7 3.8
DHA is an essential fatty acid which can be supplied directly through dietary means or 
indirectly via biosynthesis from linolenic acid. However, it has been shown that
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provision of n-3 fatty acids to mammalian embryos in the form of linolenic acid is a 
very inefficient means of supplying the target tissues with their DHA requirements 
compared with the provision of preformed DHA (Noble, R.C. & Cocchi, M. 1989a). 
The precise role of DHA in brain development remains to be ascertained, however 
evidence has accumulated which emphasizes the importance of an adequate supply of 
DHA to the neural tissues at the appropriate stages of development.
The route and mechanism of DHA delivery to the neural tissues are unknown at this 
time. Controversy exists over the form of the DHA-containing lipid species taken up 
by the brain. Studies in mammals have shown that the brain has the ability to uptake 
DHA in the form of free fatty acid bound to albumin (Anderson, G.J. & Connor, 
W.E. 1988). In which case the adipose tissue of the developing avian embryo may 
have a central role in DHA provision via its specific mobilisation of C2o-C22 fatty 
acids (Speake, B.K. et a l 1997). However remnant uptake by the liver results in the 
hepatic accumulation of TG which is highly enriched in DHA. During the hatching 
period, this DHA is transferred from TG to PL in the liver. It is possible that liver 
synthesis of very low density lipoproteins (VLDL) could incorporate this DHA 
associated with PL which is subsequently secreted into the bloodstream. As previous 
work suggested, the brain could obtain its supply of DHA from phospholipid secreted 
by the liver (Scott, B.K. & Bazan, N.G. 1989). Alternatively, studies have shown 
that DHA is preferentially taken up by the brain in the form of sn-2 lysoPC DHA 
compared to the unesterified form (Thies, F., Pillon, P., Moliere, Lagarde, M. & 
Lecerf, J. 1994). Mammalian liver has been shown to secrete lysoPC moreover there 
was a preferential release of unsaturated fatty acyl species of lysoPC (Graham, A., 
Zammit, V.A. & Brindley, D.N. 1988; Robinson, B.S., Baisted, D.J. & Vance, D.E. 
1989). Therefore the liver may direct DHA towards LysoPC synthesis and 
subsequent secretion. In any case, the liver does appear to have a pivotal role in the 
delivery of this essential fatty acid to the developing tissues.
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1.3. TRANSFER OF POLYUNSATURATED FATTY ACIDS FROM THE 
YOLK COMPLEX TO THE EMBRYONIC TISSUES.
The aim o f this study was to investigate the metabolic pathways that may be involved 
in the uptake, remodelling and delivery o f  polyunsaturated fatty acids in the chick 
during embryonic development. As discussed previously, there as been a number o f 
studies which have detailed fatty acid compositional changes which occur at various 
intervals during chick development. However, the fundamental metabolic processes 
which determine these processes have not been examined. How are fatty acids 
transferred from the yolk into the yolk sac membrane ? Which mechanisms are 
involved in the remodelling o f some fatty acids between lipid moieties from the yolk 
to the plasma ? Are some fatty acids less sensitive to p-oxidation ? How are essential 
fatty acids delivered to the developing tissues such as liver or brain ? The aim o f the 
present study was to investigate the metabolic processes in the yolk sac membrane 
and the liver which may regulate the fatty acid compositional changes previously 
found. The study o f delivery o f fatty acid to the embryonic tissues was carrying out 
by analysing the fatty acid composition o f embryonic plasma lipoproteins at different 
stages o f development.
1.3.1. Uptake of polyunsaturated fatty acid.
The transfer o f fatty acid into the yolk sac membrane occurs via a non-specific 
phagocytosis (Noble, R.C. & Cocchi, M. 1990). Previous work has demonstrated 
that the majority o f yolk DHA is associated with the PE fraction, and this is 
preferentially removed from the yolk (Noble, R.C. & Moore, J.H. 1967b). Others 
have shown that the transfer o f DHA follows a unique and different pattern from that 
o f other fatty acids (Maldjian, A. et al. 1995). Since DHA is found esterified at the 2 
position o f PE and an increased in percentage o f DHA in the free fatty acid fraction in 
the yolk was found during development (B.K. Speake, unpublished studies) an 
investigation o f phospholipase A2 activity was carried out.
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Phospholipase A2 (PLA2; e.c. 3.1.1.4.) catalyses the hydrolysis o f the 2-sn acyl ester 
bond o f a sn 3-phosphoglycerol (phospholipids and its lyso forms)
Phospholipids + action of PLA2 -------------► Free fatty acid + lysophospholipids.
This enzyme is found in snake venom, and mammalian exocrine glands, where it 
serves a digestive role. The enzyme is small, water-soluble with a molecular weight 
about 13,000-15,000 Da, they are unusually stable and require Ca2+ for optimal 
activity. The properties of this extracellular enzyme have been well documented 
(Verheij, H.M., Slotboom, A.J. & De Haas, G.H. 1981; Waite, M. 1987). Regarding 
work done on physical state o f the PLA2 substrate, lipids droplets and dense 
proteaneous granules in the yolk maybe particularly suitable for to PLA2 action 
(Dennis, E.A. 1983; Reynolds, L., Washburn, Deems, W.N. & R.A. Dennis 1991).
1.3.2. Fatty acid metabolism.
The overall metabolism of fatty acids involves a partitioning between esterification 
and oxidation See Diagram 1. Acylglycerol synthesis involves esterification o f fatty 
acids to the glycerol backbone which can occur by two distinct pathways, each 
pathway ultimately resulting in the formation of diacylglycerol. Diacylglycerol 
formation has been shown to occur either by acylation o f glycerol 3-phosphate, 
catalysed by glycerol phosphate acyl transferase (GPAT), or acylation of 
monoacylglycerol catalysed by mono-glycerol acyltransferase (MGAT). 
Diacylglycerol plays a pivotal role in the synthesis o f neutral and polar lipids. It can 
be converted into triacylglycerol, by further acylation catalysed by diacylglycerol 
acyltransferase (DGAT) or directed towards phospholipid synthesis. The oxidation of 
fatty acid occurs by p-oxidation in the mitochondria, the rate limiting enzyme o f P- 
oxidation is carnitine palmitoyl transferase I (CPT I).
Previous work (Maldjian, A. et al. 1995) has shown that in the avian embryo 
polyunsaturated fatty acids (PUFA), are transferred between lipid classes during
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transport from the yolk to the developing embryonic tissues. In particular, 
docosahexanoic acid (DHA) is found associated with the phospholipid fraction in the 
yolk then associated with the plasma triacylglycerol fraction. The present study was 
to investigate the mechanism of this PUFA remodelling, during transport across the 
yolk sac membrane. The activities of key regulatory enzymes involved in fatty acid 
oxidation (CPT I) and esterification (GPAT, MGAT and DGAT) were investigated 
throughout avian development.
Yolk lipid
Yolk sac m em brane
ESTERIFICA TIO N  OXIDATION
Lipoproteins Energy
*
Em bryo
Diagram 1 : lipid metabolism in yolk sac m em brane
26
I.3 .2 .I. Esterification of fatty  acid
The synthesis o f membrane lipids, steroids and lipoprotein involves the process of 
esterification. See Diagram 2, As described earlier, esterification o f fatty acids can 
occur either by the glycerol 3-phosphate or mono acylglycerol pathway. The rate 
limiting enzyme o f glycerol 3-phosphate pathway is glycerolphosphate acyltransferase 
(GPAT; e.c. 2.3.1.15). This enzyme catalyses the following reaction:
Sn-Glycerol 3-phosphate + Acyl-CoA -----► l-acyl-sn-glycerol 3-phosphate + CoA.
The enzyme converts water-soluble glycerophosphate to a lipid product and catalyses 
the committed step in the biosynthesis of phosphoglycerides and triacylglycerols from 
glycerophosphate. In most mammalian organs, GPAT is present in both the 
endoplasmic reticulum (microsomes) and the mitochondrial outer membrane. (Bates,
E.J. & Saggerson, E.D. 1979).
The rate limiting enzyme o f the mono-acylglycerol pathway is monoacylglycerol 
acyltransferase (MGAT e.c.2.3.1.22). This enzyme is present within the membrane of 
the microsomal fraction, and catalyses the synthesis o f sn -l,2-diacylglycerol from 2- 
monoacylglycerol and long chain fatty acyl-CoAs (Coleman, R.A., Walsh, J.P., 
Millington, D.S. & Maltby, D.A. 1986).
2-M onoacylglycerol + Acyl-CoA ► sn-l,2-diacylglycerol + CoA
It is well documented that during periods o f intense lipid oxidation, for example 
suckling rat, hibernating marmot and chick embryo a method o f protecting essential 
fatty acids from oxidation is via esterification o f sn-2-monoacylglycerols by MGAT 
(Tian Xia, Nadia Mostafa, B., Ganesh Bhat, Gregory L. Florant & Coleman, R.A. 
1993). The existence o f such a mechanism in the yolk sac membrane may protect 
essential fatty acids from oxidation.
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Diagram 2.: Biosynthetic pathway of triacylglycerols and phospholipids: 
GPAT (glycerol phosphate acyltransferase). MGAT (monoacylglycerol 
acyltransferase). DGAT (diacylglycerol acyltransferase).
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Diacylglycerol acyltransferase (DGAT e.c.2.3.1.20) catalyses the committed step in 
the formation o f triacylglycerol and possibly has a regulatory role in the supply o f TG 
for lipoprotein synthesis (Owen, M.O., Corstophine, C.C. & Zammit, V.A. 1997). 
1.2 diacylglycerol acyltransferase (DGAT) is associated with a complex, bound to the 
surface o f the endoplasmic reticulum membrane. It catalyses the following reaction:
Diacylglycerol + Acyl-CoA ------------- ► triacylglycerol + CoA
Investigation o f this enzyme in the yolk sac membrane and the liver was carried out to 
provide information on the ability o f these tissues to synthesis triacylglycerol a 
prerequisite for lipoprotein assembly.
I.3.2.2. Oxidation.
Fatty acids are a major source o f energy for the heart and for skeletal muscle. In the 
chick during the second period o f embryogenesis when there is a high transfer o f fatty 
acid from the yolk to the embryo, the energy required is provided by fatty acids 
oxidation (Noble, R.C. & Cocchi, M. 1990). The role o f carnitine palmitoyl 
transferase I (CPT I) and its regulation by malonyl CoA has been extensively 
investigated, (for review McGarry, J.D. & Brown, N.F. 1997). Long chain fatty acids 
esterified to CoA in the extramitochondrial compartment o f the cell gain access to the 
enzymes o f oxidation in the mitochondrial matrix by a carrier system that uses 
carnitine. The rate limiting reaction o f this carrier system is catalysed by carnitine 
palmitoyl transferase I. The products o f this reaction are acyl-camitine and free CoA. 
The liberated CoA is transported back into the cytosol and the acyl-camitine is carried 
through the second membrane and reacts with a CoA in the matrix. This second 
reaction is catalysed by CPT II. See diagram 3. The released carnitine is transported 
to the extramitochondrial compartment. The newly formed acyl-CoA can now enter 
the oxidation cycle (Eaton, S., Bartlett, K. & Pourfarzam, M. 1996).
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Diagram 3: Roles of carnitine palmitoyltransferase I and II (CPT I and 
CPT II) in the mitochondrial transport of fatty acid. Inhibitor, Malonyl 
CoA (MCoA). Diagram inspired from McGarry et aL (McGarry, J.D., 
Esser, A.S.V., Woeltje, K.F., Weis, B. & Foster, D.W. 1991).
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1.3.3. PUFA transport.
Synthesis and secretion of lipoproteins by the yolk sac membrane in the developing 
chick embryo has been well described (Noble, R.C. & Cocchi, M. 1990; Shand, J.H., 
West, D.W., McCartney, R.J., Noble, R.C. & Speake, B.K. 1993). During the 
earliest period o f transfer o f fatty acids, lipids are assembled into lipoproteins by the 
yolk sac membrane and secreted. In the liver, a store o f cholesteryl ester (CE) 
accumulates during the last period o f embryonic life (Shand, J.H. et al. 1994) and 
after hatching is secreted as a component o f a lipoprotein (Noble, R.C. 1987; Tarugi, 
P., Nicolini, S., Marchi, L., Ballarini, G. & Calandra, S. 1994). As development 
proceeds the yolk sac membrane lipoprotein secretory role diminishes in line with 
decreased yolk content and decreased rate o f lipid transfer. At around hatching it is 
the liver which is the major producer o f plasma lipoproteins. No detailed analysis of 
fatty acid composition has been performed on the different plasma lipoproteins at 
different stages o f development but results from Maldjian, A. (1996) showed that high 
transfer o f DHA occurs from day 12 to day 15, on the other hand at hatching all the 
DHA had been transferred to the embryo. As discussed, yolk PUFAs are delivered to 
the embryo as part o f a lipoprotein particle, therefore analysis o f different plasma 
lipoproteins at different period would provide key information on how the embryo 
metabolises these PUFAs.
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MATERIALS AND METHODS
2.1. PREPARATION OF THE TISSUES
2.1.1. Embryos.
Fertile eggs from Ross 1 broiler-breeder parents were obtained from a commercial 
poultry supplier (Ross poultry: Thornhill, Scotland). They were incubated at 37.5°C 
and 60% relative humidity in a force draught incubator with automatic egg turning. 
Hatching occurred after 21 days o f incubation and chicks were maintained for one 
day with access to drinking water but no food provision.
2.1.2. Sample collections for enzyme assay.
At each developmental stage studied, several eggs were opened and the embryos were 
gently dissected from their yolk complex (i.e., yolk plus yolk sac membrane). The 
liver was removed and washed with sucrose buffer (Sucrose, 250 mM, TRIS, 5 mM, 
EGTA 1 mM, pH 7.4 @ 0 °C). The yolk sac membrane was washed extensively with 
cold NaCl 0.85% to remove residual yolk. Tissue samples were kept on ice prior to 
subcellular fractionation. Yolks were transferred carefully without any presence of 
blood into plastic vials and stored at -80°C prior to further analysis.
Tissue samples were finely chopped using scissors and gently homogenised in sucrose 
buffer using a glass/teflon homogeniser. Subcellular fractionation was carried out by 
differential centrifugation. Homogenised samples were centrifuged at 400 g for 10 
minutes at 4°C. The resulting supernatant was centrifuged at 4000 g, for 10 min to 
isolate mitochondria. The yolk lipid, cell debris and blood cells were discarded. The 
supernatant was centrifuged in an ultracentrifuge (Centrikon T.11XO, Kontron 
Instruments) at 100,000 g for 1 hour to prepare microsomes. The mitochondrial 
pellet was washed in sucrose buffer and recentrifuged at 4000 g for 10 min. 
Mitochondrial and microsomes were finally resuspended in sucrose buffer and stored
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at -80°C. Mitochondria for the CPT 1 assay, were resuspended in KC1 buffer (KC1 
150 mM, TRIS 5 mM, EGTA 1 mM, pH 7.4 at 0 °C) and placed on ice.
2.1.3. Extraction of plasma lipoproteins.
2.1.3.1. Blood collection for lipoprotein analysis.
On day 14 of incubation, 20 embryos were sacrificed and blood was collected from 
the blood vessel associated with the embryonic chorioallantoic membrane which lies 
just beneath the shell. The anti coagulant EDTA (Diaminoethanetetra-acetic acid 
disodium salt) was added to the blood at a final concentration o f 3 mg/ml. The blood 
collected was pooled, due to the small volume obtained per embryo. Blood was also 
collected on day 22 (1 day post hatch). This blood sample was obtained from 20 
chicks by decapitation. The blood samples were left at 4 °C for 1 hour.
2.1.3.2. Isolation of plasma lipoproteins.
Blood samples were centrifuged at 3000 g at 4°C, for 20 min. in a benchtop 
centrifuge (ALC, Camlab). Blood plasma was collected and the volume measured. 
The following reagents were added to the plasma: Phenylmethylsulfonyl fluoride 
(0.015%), EDTA (0.04%) to prevent lipoprotein modification and Sodium Azide 
(0.05%) to prevent bacterial growth (all final concentration).
Lipoproteins were separated by density gradient ultracentrifugation. A solution of 
NaCl/KBr (density 1.346 g/ml) was used to adjust the plasma salt density to the 
appropriate level to allow the separation o f the different lipoprotein species. VLDL, 
IDL, LDL and HDL were isolated from plasma at density 1.006 g/ml, 1.019 g/ml, 
1.063 g/ml and 1.21 g/ml respectively. The plasma was transferred into centrifugation 
tubes and laid over with saline at an equal density to create a discontinuous gradient.
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Samples were centrifuged at 100,000 g for 18 hours at 12 °C in a ultracentrifuge 
(Centrikon T.11XO, Kontron Instruments) using a horizontal rotor. Centrifugation 
gave sequential isolation of the lipoprotein fraction by flotation to the top of the tube. 
Each lipoprotein fraction was removed, stored under N2 at -20 °C.
2.1.4. Sample collection for lipid analysis.
As previously, embryos were sacrificed, embryos were excised from the eggs and 
carefully separated from their associated yolk complexes. A maximum volume of 
yolk was collected without any blood contamination.
2.1.5. Protein analysis.
Mitochondrial and microsomal protein concentration were determined by the method 
of Lowry (Lowry, O.H., Rosebrough, N.J., Fan, A.L. & Randall, R.J. 1951) with 
bovine serum albumin (BSA) as standard.
2.I.5.I. Assay of lipoprotein protein.
Lipoprotein was determined following the method of Lowry et al. (1951) with a few 
modifications. A mixture consisting of 50 mis of reagent A (2% disodium carbonate, 
0.4% sodium hydroxide, 0.16% potassium tartrate and 1% sodium dodecyl sulphate), 
and 0.5 ml o f reagent B (4% cupric sulphate) was prepared and 3 ml of this solution 
added to duplicate lipoprotein samples total volume 0.2 ml. Tubes were incubated at 
room temperature for 10-60 min., after which, 0.3 mis of diluted Folins and 
Ciocalteu reagent (1:1 v/v) was added. The tubes were incubated for further 45 min.. 
The absorbance was read against blank sample at 660 nm.
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2.2. ENZYM E ASSAYS
2.2.1 G lycerolphosphate acyltransferase (G PA T e.c. 2.3.1.15).
The enzyme converts water-soluble glycerophosphate to a lipid product and catalyses 
the committed step in the biosynthesis o f phosphoglycerides and triacylglycerols from 
glycerophosphate. GPAT was assayed in both mitochondrial and microsomal 
fractions. N-ethylmaleimide was used to inhibit microsomal GPAT (Bates, & 
Saggerson, E.D. 1979).
2.2.1.1. Analytical method.
GPAT was assayed radiochemically at 30°C by following the incorporation o f [14C]- 
glycerol 3-phosphate into butanol-soluble products. Assays were performed in a final 
volume o f 0.25 ml containing 50 mM TRIS/HC1 buffer pH 7.4, KC1 120 mM, 0.2 
mM dithiothreitol (freshly prepared), defatted B.S.A. 4 mg/ml, palmitoyl-CoA 100 p 
M, 0.2 pCi [14C]-glycerol-3-phosphate, unlabelled sn-glycerol 3-phosphate (G.3.P.) 3 
mM. A concentration o f 3 mM G.3.P. was found to be saturating for GPAT activity 
in the yolk sac membrane. This concentration was also used for measuring GPAT 
activity in the liver since the activity in this tissue was lower.
Assay samples were preincubated for 3 min at 30°C on a heated block. The reaction 
was started with 50 pg o f either microsomal protein or mitochondrial protein from the 
yolk sac membrane and 50 - 100 pg microsomal protein from the liver. Assay of 
GPAT activity in the yolk sac membrane was terminated after 5 minutes. Liver 
GPAT assay was terminated after 10 minutes. This was due to the lower activity o f 
the liver enzyme compared to the yolk sac membrane enzyme and also due to the 
limitations o f quantity o f microsomal protein available. The reaction was stopped by 
adding 2.0 ml o f water saturated 1-butanol to each tube, vortexed, and placed in ice. 
A volume o f 0.75 ml o f butanol-saturated-water was added, vortexed, and the mixture 
centrifuged at 600 g in a bench top centrifuge for 10 min. at room temperature. The
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upper butanol layer was transferred to fresh tubes and was washed with 1.3 ml 
butanol-saturated-water. The wash was repeated twice, the tubes were vortexed and 
centrifuged for 3 min. at 600 g. 1 ml o f the washed butanol layer was transferred to a 
scintillation vial and 10 ml o f Opti-fluor (Packard company) added. Radioactivity 
associated with the organic phase was determined using a scintillation counter (1900 
TR, Liquid Scintillation Analyser, Packard company).
The results are expressed in nmols/min/mg o f either microsomal or mitochondrial 
protein.
2.2.2. Diacylglycerol acyltransferase (e.c. 2.3.1.20).
As described below, DGAT activity was measured by following the esterification o f 
[14C]-palmitoyl Co A into [14C]-triacylglycerol. The products were extracted into 
heptane, using the method described by Jamdar & Cao (Jamdar, S.C. & Cao, W.F. 
1995).
2.2.2.I. Analytical method:
DGAT was assayed in the presence o f 1,2 diacyl-sn-glycerol dispersed in 0.1% 
Tween-20 and [14C]-palmitoyl Co A. The standard assay was in a final volume o f 0.5 
ml, containing 50 mM TRIS-HC1 pH 7.5, 10 mM Mg S 0 4, 1.2 mM diacylglycerol, 
0.04 mg/ml dithiothreitol, 1.25 mgB.S.A. fat free, 100 pM  palmitoyl CoA with 0.1 p 
Ci o f [14C]-palmitoyl CoA (Ci/mole). The substrate concentration used was 
saturating, and the reaction was linear with time. The reaction was started with the 
addition o f enzyme and the samples were incubated at 37°C for 10 minutes. The 
reaction was terminated by adding 0.75 ml o f a “stop mixture” containing 2-propanol/ 
heptane/ water (80:20:2 v/v/v), the tubes were vortexed briefly and placed on ice. 
After 5 minutes, 0.5 ml o f heptane and 0.25 ml o f distilled water was added to each 
tube. The tubes were centrifuged at 600 g for 5 min. in a bench top centrifuge. The
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heptane layer (upper phase) was transferred into fresh test tubes, and washed twice 
with 1 ml of “wash mixture” containing 0.5 N NaOH/ ethanol/ water (10:50:50 v/v/v) 
and centrifuged at 600 g for 5 min. following the first wash and for 10 min. following 
the second wash. The radioactivity associated with the organic phase was measured 
using a scintillation counter. A volume of 0.15 ml of heptane was transferred to 
scintillation vials, and 1 0  ml of opti-fluor was added.
The reaction products formed in the DGAT assay were identified as di- and 
triacylglycerol following thin-layer chromatography of 0.25 ml of the heptane phase. 
The major reaction product formed in this assay was identified as [14C]- 
triacylglycerol. The specific activity of DGAT was calculated on the basis of 
radioactivity in the TG fraction minus the radioactivity present in the 
monoacylglycerol and diacylglycerol fraction.
2.2.3. Monoglycerol acyltransferase (MGAT e.c.2.3.1.22).
Monoacylglycerol acyltransferase (e.c.2.3.1.22) present within the membrane of the 
microsomal fraction catalyses the synthesis of sn -l,2 -diacylglycerol from 2 - 
monoacylglycerol and long chain fatty acyl-CoAs (Coleman, R.A. et al. 1986). 
MGAT activity was determined by measuring the conversion of [14C]-palmitoyl CoA 
to [14C]sn-1.2 diacylglycerol as described by Jamdar & Cao (1995).
2.2.3.I. Analytical method:
MGAT was assayed in the presence of 2-monoolein dispersed in 0.1 % Tween 20 
(v/v). The reaction mixture contained 24 mM TRIS/HC1 buffer pH 7.5, 50 mM KC1,
8.0 mM M gS04, 0.25 mM 2-monoolein, 0.75 mM dithiothreitol, 1.25 mg/ml of free 
fat B.S.A., 25pM [14C]-palmitoyl CoA (0.02 pCi/mole) and 20 pi of the 
phospholipid mixture (15 pg of PC/ 15 pg of PS 1:1, w/w), in a final volume of 0.5 
ml.
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The reaction mixture was preincubated at 37 °C for 5 min. and the reaction started by 
addition o f 2 pg microsomal protein in a volume of 20 pi. The reaction was 
terminated after 5 min. by the addition o f 0.75 ml o f “stopping mixture” containing 2- 
propanol/ heptane/ water (80:20:2 v/v/v). After 5 min., 0.5 ml o f heptane and 0.25 ml 
o f water was added and the tubes were centrifuged at 600 g for 5 min. The heptane 
layer was removed to fresh tubes, and washed twice with 1 ml o f “wash mixture” 
containing 0.5 N NaOH/ ethanol/ water (10:50:50 v/v/v) and centrifuged at 600 g for 
5 min. (as DGAT). A volume o f 0.25 ml o f heptane was removed and the 
radioactivity measured using a scintillation counter. The remaining heptane was dried 
and the lipids separated by TLC in a heptane/ isopropyl ether/ acetic acid (60:40:4 
v/v/v) solvent system. Carrier lipids (monoacylglycerol/ diacylglycerol/ 
triacylglycerol) were added to help visualisation. Radioactivity associated with the 
DG and TG fractions were measured using a scintillation counter.
The specific activity o f the MGAT pathway was calculated on the basis of 
radioactivity present in the DG fraction plus V2 of the radioactivity in the TG fraction, 
(as 2 moles o f palmitoyl-CoA were required to form TG from 2-monoacyIglycerol).
2.2.4. Carnitine palmitoyl transferase I (CPT1).
CPT I activity was measured as described Kolodziej (Kolodziej, M.P., Crilly, P.J., 
Corstorphine, C.G. & Zammit, V.A. 1992). The reaction was measured by following 
the conversion of [3H]-carnitine to [3H]-palmitoyl-camitine. The product was 
extracted from [3H] -carnitine using water saturating butanol. The activity o f CPT I 
can be inhibited by the presence o f malonyl CoA (McGarry, J.D., Esser, A.S.V., 
Woeltje, K.F., Weis, B. & Foster, D.W. 1991). The sensitivity o f CPT I to malonyl- 
CoA was measured by assaying CPT I activity in the presence o f increasing 
concentrations o f malonyl-CoA.
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2.2.4.1. Analytical method:
CPT I was assayed in a reaction mixture containing: 5 mM TRIS/ HC1 pH 7.4, 150 
mM KC1 1 mM EGTA, 0.02 g of B.S.A. fat free, 5 mM MgCl2, 5 mM ATP, 1 mM o f 
dithiothreitol, 2 pg/ml antimycin A, 4 pg/ml rotenone in a final volume o f 1 ml. 
Maximum CPT I activity was measured in the presence o f 250 pM  o f palmitoyl-CoA. 
Malonyl CoA sensitivity was measured in the presence o f 35 pM  palmitoyl CoA.
The reaction was started by addition o f 25 pi o f sample, concentration usually 10 
mg/ml protein. The tubes were mixed and incubated for 2 min. at 37 °C. Following 
this incubation period 25 pi of [3H] -carnitine (0.5 mM, 0.35 Ci/mol) was added to 
each tubes and the samples incubated for 2 min. The reaction was stopped by 
addition o f 300 pi o f 6N  HC1. The tubes were then mixed and placed immediately on 
ice. The [3H]-palmitoylcamitine formed was quantified as described below. 
Distilled water (1 ml) and 4.5 ml o f water saturated butanol was added to each tube. 
Each tube was shaken manually for at least 3 min. and then centrifuged at 600 g using 
a bench top centrifuge. The upper butanol layer was transferred into fresh tubes using 
a Pasteur pipette. The butanol phase containing [3H] -palmitoylcamitine was washed 
4 times with 3 ml o f butanol saturated water. A 3 ml aliquot o f the butanol phase was 
transferred into scintillation vials with 10 ml o f Opti-fluor (Packard company).
Maximum CPT I activity was expressed as pmoles [3H]-palmitoylcamitine formed 
per minute per mg o f mitochondrial protein. Sensitivity to malonyl-CoA was 
expressed as the concentration o f malonyl-CoA (pmole) which illicited 50 % 
inhibition.
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2.2.5. Phospholipase A2 assay using pyrene-labeled acyl chains on eggs' 
components.
2.2.5.1 Analytical m ethod:
Samples were prepared from the egg yolk and whole yolk sac membrane from day 10 
to day 16 o f development. The fluorescent phospholipid used was l-hexadecanoyl-2- 
(l-pyrendecanoyl)-sn-glycero-3-phosphoethanolamine (P-py-Ci0-HPE). In an 
attempt to form vesicles with the same composition as lipid droplets present in the 
yolk, phospholipids were extracted from egg yolk and used to produce liposomes. A 
standard curve was made by measuring the light intensity o f different concentrations 
o f 1-pyrenedecanoic acid, the product o f hydrolysis.
2.2.5.2. Liposomes preparation.
Liposomes were prepared according to the procedure o f Batzri & Korn (Batzri, S. & 
Korn, E.D. 1973). Liposomes were formed from a mixture o f yolk phospholipids 
(average o f 760 g/mole corresponding o f the major phospholipids present in the yolk 
fraction) and P-py-Cio-HPE (m.w.: 808.05 g/mole), final concentration (in cuvette) o f 
1 mmole and 5 pmole, respectively. Phospholipids and substrate were dried under 
nitrogen and suspended in methanol/ ethanol (2 :1, v/v) to obtain a concentration 
between 20-40 pmoles o f phospholipid/ml (Batzri, S. & Korn, E.D. 1973).
The ethanoloic lipids were rapidly injected into an Amicon filtration cell containing 10 
ml of saline buffer (40 mM TRIS-HC1, pH 7.4, 2 mM CaCl2) to form liposomes. 
Liposomes were concentrated to approximately 2 ml volume under 10 psi pressure. 
The liposomes were washed in a further 10 ml o f warm buffer and filtered down to 
approximately 1-2 ml. Filtrates were discarded and the liposome preparation, which 
appeared with a slight translucent blue-brown colour was diluted up to 6 mis using the 
appropriate buffer. Liposome preparation were stable for up to one week at
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temperatures below 4 °C and light protected. The substrate was very sensitive to the 
light.
2.2.5.3. Preparation of the samples.
Yolk protein was isolated as an acetone/diethyl ether-dried preparations (Parkin, 
S.M., Speake, B.K. & Robinson, D.S. 1982). Yolk and whole yolk sac membrane 
protein were blended in distilled water at 4°C (1/1, v/v) and 15 ml o f cold acetone 
was added to the sample. The homogenates were centrifuged at 800 g for 20 min. at 
4 °C. The acetone layer was discarded and the protein pellets were washed a second 
time with 15 ml o f acetone, centrifuged at 800 g for 20 min at 20 °C and the top layer 
discarded. The pellets were resuspended in 15 ml o f diethyl ether and dried down 
under vacuum. The defatted dried residue was resuspended in CaCl2 buffer and 0.1 % 
Triton X-100, to disperse the sample.
2.2.5.4. The assay.
Liposomes were resuspended in appropriate volume o f CaCl2 buffer (40 mM TRIS, 2 
mM CaCl2, pH 7.4) in a heated (37.5°C) and magnetically stirred (low speed to avoid 
bubble formation) cuvette. Excitation wavelength o f 341 nm and emission 
wavelength o f 376 nm were selected by Perkins Helmer software (Instrument control 
V.4,0). The fluorescence measurement was carried out using a Luminescence 
spectrophometer (Perkin Helmer, Beaconsfield, U.K.). The fluorescence spectrum of 
the substrate is shown on Figure 4. The corresponding slits were 2.5 nm. The 
fluorescence o f the reaction medium (Blank) was recorded and the reaction was 
initiated by the addition o f the protein sample. Optimal assay conditions, i.e. CaCl2 
concentration, pH optimum, protein concentration were determined. All PLA2 
activity assayed was found to be Ca2+ dependant, a concentration o f 2 mM was used 
to assay yolk samples and 4 mM of CaCl2 was used for yolk sac membrane samples. 
A protein concentration o f 200 pg was assayed for the determination o f whole yolk
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sac membrane PLA2 activity, 1 0 0  p.g was used to assay yolk PLA2 activity. The activity was 
expressed in pmole per minute per mg of protein. The enzyme activity was determined by 
measuring the slope of the curve representing the increase of fluorescence versus time, see 
Figure 5.
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Figure 4: Fluorescence emission spectra of P-py-Cio-HPE. Emission spectra were 
recorded in 40 mM TRIS, 2 mM of CaCI2, pH 7.5, containing 5 pinole of substrate 
inserted in 1 mmole forming liposome. Excitation wavelength sets at 341 nm, slit 2.5.
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Figure 5: Fluorescence emission spectra of sample with m itochondria protein. The 
assay was performed by injecting 200 pg of mitochondrial protein into the cuvette, 
the reading was made at 376 nm. The slope of the curve was determined by 
deriving the function given (Excel 5). The activity was measured at the maximal 
rate.
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2.3. LIPID ANALYSIS
2.3.1 Lipid extraction.
Lipid extraction was carried out as described by Christie (Christie, W.W. 1982). 
Yolks were homogenised in chloroform/ methanol (2:1, v/v). The homogenates were 
then filtered through a Whatman filter paper (reference n°l, Whatman labscales Ltd, 
Kent, U.K.) into measuring cylinders. The deposits on the filter papers were washed 
with an excess of solvent. Such chloroform/ methanol extracts are known to contain 
sugars, urea, salts and amino acids in addition to lipids, these were removed by 
addition of an aliquot of KC1 (0.88%, w/v). After shaking, the mixture was left to 
stand overnight, to allow separation of aqueous and organic phases. The upper 
“aqueous phase” was discarded and the lower “organic phase” containing the lipids 
was transferred to a round bottom flask and the solvents evaporated using a rotary 
evaporator (in a water bath at 55 °C). The lipid extracts were then dissolved in a 
known volume of chloroform (10 ml). Addition of a small amount of methanol was 
sometimes necessary if a small amount of water was still present in the samples. In 
such cases, samples were dried again and the operation was process until the lipid 
extract in chloroform was perfectly clear. The final chloroform extract was 
transferred into glass vials and stored in the fridge. A aliquot (usually half) of the 
chloroform extract was dried in preweighed round bottom flasks to determine the 
weight of total lipid in the sample. An aliquot of the remainder of the lipid extract 
(i.e. that which was not dried for gravimetric determination) was used for the 
determination of the fatty acid composition of the total lipid and to extract individual 
lipid classes by thin layer chromatography.
2.3.2 Separation of lipid classes by thin layer chromatography (TLC)
20 x 20 cm glass plates were cleaned with cotton wool dampened with hexane. The 
stationary phase was Kieselgel 60 G (Merck, ATG, Darmstadt, Germany). 22.5 g of
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silicate K 60 in 50 ml o f distilled water was required to spread 5 plates. This phase 
was applied to the plates using an aluminium spreader which was adjusted to deliver 
a layer o f silica gel o f defined thickness (0.25 mm). Plates were allowed to dry for 
30 min at room temperature and were then transferred to an oven for a minimum 
period o f 30 min at 110°C. Plates were left to cool at room temperature before 
sample application. The eluting solvent was hexane/ diethyl ether/ formic acid 
(80:20:1, v/v/v), prepared fresh. 200 ml of this eluting solvent was added to the 
chromatank, which was lined with filter paper and sealed with a glass cover, and the 
system was allowed to equilibrate for 30 min before beginning the chromatography. 
Lipid dissolved in chloroform was applied to the plate at 1 cm from the base, using a 
500 pi glass syringe. The applications were allowed to dry at room temperature 
before the plates were placed carefully into the chromatank. When the solvent front 
reached 1 cm from the top of the plate (after approximatly 45 min.) plates were 
removed from the chromatank and air dried for a few seconds. They were then 
sprayed with Trifluorofluorescence and the bands representing the lipid classes 
visualised. The following Diagram 4 shows the lipid class separation obtained under 
these conditions:
MIGRATION
Typical R f ---------------------------------------------
0 . 9 4  Cholesterol ester J i
0.75 Triacylglycerol
Free fatty acid
0.45
Free cholesterol ------------------------------------
0.21
Phospholipid
Diagram 4: Separation of lipid classes by thin layer chrom atography.
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Bands were scraped from the plates and the lipid extracted using diethyl ether, the 
phospholipid was extracted using methanol. The lipid extract was centrifuged at 600 
g for 2 min. At this stage, the extracted lipids were either methylated for fatty acid 
composition analysis or transferred to a glass vial of known weight, to determine the 
amount of each lipid class. Free cholesterol was determined by an 
enzymatic/colourmetric method using a Boehringer Kit System (Lewes, East Sussex, 
England).
2.3.3. Methylation of fatty acids
A volume of 1 ml of pentadecanoic (C 15) standard was added to each lipid extract. 
This allows quantification of the fatty acid peaks by comparison of their retention 
times with that of the C 15 standard using gas chromatography (GC). Lipids fractions 
were transferred to round bottom flasks and reduced to dryness, 4 ml of the 
methylating agent (methanol/ toluene/ sulphuric acid: 20:20:1 v/v/v) was added. The 
samples were refluxed for at least 30 min and then allowed to cool. Once cold, 10 ml 
of water and 10 ml of hexane were added. The tubes were shaken vigourously and 
samples poured into B19 test tubes. Two layers formed rapidly; the upper hexane 
layer was transferred into clean test tubes containing a small amount of the drying 
agent, sodium sulphate/ sodium hydrogen carbonate (4:1 w/w). The tubes were left 
to stand for a minimum of 30 min.. The hexane was then transferred into smaller 
tubes and left until GC preparation and analysis.
2.3.4. Gas chromatography analysis
Samples were concentrated by drying under gas nitrogen, and then dissolved in a 
minimum volume of hexane. Samples were analysed using a autosampler CP9001 
GC (Chrompack, Middleburg, The Netherlands). It was equipped with a 30 m by 
0.25 mm capillary column fitted with a 3.0 m by 0.25 pm retention gap (Carbowax, 
Alltech associates, Camforth, U.K.). Temperature was set at 185 °C for 2 min, then
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raised to 230 °C at a rate of 5°C/min. The helium carrier gas was maintained at a 
flow rate of 2 5 cm/sec. Injection volume was 50 j l x I  and the split ratio was 1:50. The 
detector was a flame ionisation detector with a hydrogen flow of 30 ml/min. Air 
flow was 300 ml/min. The make up flow of nitrogen was 30 ml/min. The injector 
and FID temperature was 250 °C. Identities of the peaks were verified by 
comparison with the retention times of the standard fatty acid methyl ester and with 
proprietary methyl ester mixtures of known composition (Sigma Chemical LTD, 
Pool, U.K.).
2.4. EXPRESSION OF THE RESULTS.
All data are expressed as the mean ± S.E.M. of at least 3 replicate samples. Where 
appropriate, statistical analysis were performed using an unpaired Student’s t-test.
Significant differences where expressed as following: aP<0.001; bP<0.005; CP<0.01; 
dP<0.025; eP<0.05.
2.5. MATERIALS
Chemicals were purchased from Sigma Chemical LTD. Palmitoyl-CoA from 
Pharmacia (Biotech, U.S.A.) [14C] glycerol-3-phosphate di-sodic ( ethanol/water 1:4 
v/v) purchased from I.C.N. Bovine Serum Albumin fat free (B.S.A.) from Advanced 
Protein Product LTD. [ 14C]palmitoyl CoA, (sodium acetate pH 5.9-6.0) and [3H] - 
Carnitine (L-(methyl- H) carnitine hydrochloride) were from Amersham, U.K. 1- 
hexadecanoyl- 2  ( 1 -pyrendecanoyl) sn-glycero-3-phosphoethanolamine (P-py-Cjo- 
HPE) and 1-pyrenedecanoic acid from Molecular Probes Company.
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RESULTS
INTRODUCTION
As discussed previously a number o f key features o f PUFA metabolism occurs from 
around day 12 to day 16 o f avian development. We therefore decided to investigate a 
number o f metabolic parameters from day 10 to day 16. In some cases obtaining 
sufficient material was our limiting factor and this precluded detailed analysis at some 
developmental points.
3.1. FATTY ACID ANALYSIS IN TH E E G G  Y O L K  DURING 
DEVELOPM ENT.
Previous work has analysed the fatty acid composition o f  the yolk complex which 
comprises both the yolk and the yolk sac membrane. The present analysis was 
performed on yolk lipid only during embryonic development (Table 10). The 
majority o f fatty acids were associated with the triacylglycerol fraction, with 63.9 ± 
0.3 % (% w/w o f total lipid). Phospholipid (PL) was the second major lipid class with
29.4 %. The other lipid classes, cholesteryl ester (CE), free cholesterol (FC) and free 
fatty acids (FFA) were present but at a lower percentage. During development, the 
percentage o f TG increased from day 0 to day 16, whereas the percentage o f PL 
slightly decreased. The proportion o f CE and FC remained similar throughout 
development. The percentage o f ratio o f FFA increased from 0.79 ± 0 .1  to 1.62 ± 
0.3 %.
3.1.1. F atty  acid composition of yolk triacylglycerol (Table 11).
At day 0, oleic acid was found to be the major fatty acid (44.1 ± 1.4 %, % w/w o f 
total fatty acid) associated with the TG fraction following by palmitic acid with 25.8 ± 
0.5 %. Linoleic acid was the major polyunsaturated fatty acid (PUFA) present in the
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the TG fraction with 14.1 ± 0.5 %. Linoleic, arachidonic (AA; 20:4) and 
docosahexaenoic acid (DHA; 22.6) percentage were below 1 %.
3.1.2. Fatty acid composition of yolk phospholipid (Table 12).
At day 0, palmitic and oleic acid were the major fatty acids present under the PL 
fraction with 27.4 ± 0.9 and 22..5 ± 1 .4  % (% w/w of total fatty acid) respectively. 
Linoleic acid was the major PUFA in PL with 17.5 + 1.0 %. In agreement with 
earlier findings (Noble, R.C. & Cocchi, M. 1990) DHA and AA were present in egg 
yolk PL with 6.16 ± 0.2 and 5.41 ± 0.4 % respectively. From day 0 to day 16 of 
development the percentage of the major fatty acids increased slightly whereas the 
percentage of DHA decreased by more than 60 % from 6.16 ± 0.2 to 2.32 + 0.1 %. 
This pattern was not found for the other PUFA.
3.1.3. Fatty acid composition of yolk free fatty acid (Table 13).
At day 0, oleic and palmitic acid were the major fatty acid with 32.9 ± 0.5 and 18 ±
2.0 (% w/w of total lipid) respectively. Linoleic acid was the major PUFA with 17.5 
± 1.0 %. DHA and AA were present at less than 5 %. The free fatty acid (FFA) 
composition was found to change during development. The percentage of stearic and 
oleic acid slightly decreased whereas the percentage of palmitic, palmitoleic and 
linoleic increased. Interestingly the percentage of arachidonic acid and DHA in the 
FFA fraction increased to day 10 then decreased towards day 16. This was 
particularly evident for DHA, as illustrated in Figure 6. The decrease of DHA 
within the PL fraction was associated with an increase of DHA in FFA fraction. No 
significant differences were found within the cholesteryl ester class (CE) and the 
triacylglycerol class (TG).
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Table 10: Yolk lipid class composition (% w/w of total lipid) during
development. Values are means ± n=4
Days o f development 0 10 12 14 16
Lipid class (%, w/w of lipid content)
Triacylglycerol 63.9 ±0.3 63.4 ±0.6 65.8 ±0.4 66 ±0.7 67.1+0.7
Phospholipid 29.4 ±0.2 28.3 ±0.4 27.2 + 0.3 27.2 + 0.6 25.5 ±0.7
Free fatty acid 0.79 ±0.1 2.04 ± 0.5 1.31 ±0.3 1.63 ±0.4 1.62 + 0.3
Cholesteryl ester 1.21 ± 0.1 2.35 + 0.4 1.05 ±0.1 0.92 + 0.0 1.33 ±0.1
Free cholesterol 4.73 ±0.4 3.91 ±0.4 4.62 ±0.1 4.29 + 0.1 4.44 + 0.0
Table 11: Fatty acid composition (% w/w of total 
triacylglycerol. Values are means ± S.E.M., n=4
I lipid) of yolk
Days of development 0 10 12 14 16
Fatty acid (% w/w of lipid content)
Palmitic 25.8 ±0.5 26.5 ±0.5 25.3 ±0.6 26.6 ± 0.2 27 ± 0.7
Palmitoleic 3.06 ± 0.1 3.54 ±0.2 3.43 ±0.6 3.89 ±0.5 3.93 ±0.3
Stearic 7.17 ± 0.3 7.13 ±0.2 6.74 ±0.4 6.76 ±0.3 7.01 ±0.3
Oleic 44.1 ± 1.4 43.3 ± 1.6 45.2 ±2.1 42 ± 1.2 43.4 ± 1.5
Linoleic 14.1 ±0.5 14.1 ± 1 13.9± 1.2 15.1 ±0.6 13.2 ±0.8
Linolenic 0.67 ±0.1 0.64 ±0.1 0.63 ±0.1 0.67 ±0.1 0.54 ±0.0
Arachidonic 0.33 ±0.0 0.27 ±0.0 0.28 ± 0.0 0.29 ±0.0 0.25 ± 0.0
Docosahexaenoic 0.3 ±0.1 0.18 ± 0.0 0.18 ± 0.0 0.19 ±0.0 0.2 ± 0.0
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Table 12: Fatty acid composition (% w/w of total lipid) of yolk
phospholipid. Values are means ± S.E.M., n=4
Days o f development 0 10 12 14 16
Fatty acid (% w/w of total lipid)
Palmitic 27.4 ±0.9 28.7 ±0.4 27.6 ±0.2 29.1 ±0.3 28.7 ±0.3
Palmitoleic 0.93 ±0.1 1.14 ± 0.1 1.06 ± 0.2 1.24 ±0.1 1.17 ±0.1
Stearic 17.1 ±1.3 15.9 ±0.2 17.3 ±0.3 16.3 ±0.2 18.1 ±0.4
Oleic 22.5 ± 1.4 23.4 ±0.9 24.9 ±0.9 24.4 ±0.6 25.3 ±0.8
Linoleic 15.2 ±0.8 15.7 ±0.6 14.8 ±0.8 15.1 ±0.3 15.4 ±0.6
Linolenic 0.15 ±0.0 0.17 ± 0.0 0.11 ± 0.0 0.13 ±0.0 0.14 ±0.02
Arachidonic 5.41 ±0.4 5.33 ±0.2 5.04 ±0.1 4.91 ±0.1 4.64 ±0.1
Docosahexaenoic 6.16 ± 0.2 4.74 ±0.3 4.18 ±0.3 3.94 ±0.3 2.32 ±0.1
Table 13: Fatty acid composition (% w/w of total lipid) of yolk free fatty 
acid. Values are means ± S.E.M., n=4
Days o f development 0 10 12 14 16
Fatty acid (%  w/w of total lipid)
Palmitic 18 ± 2.0 14.2 ±0.9 19 ±0.6 19.4 ± 1.5 19.6 ±0.9
Palmitoleic 2.45 ±0.3 1.51 ±0.3 4.08 ±0.9 4.46 ±0.5 5.19 ±0.8
Stearic 13.8 ±1.4 11.9 ± 1.9 8.9 ± 1.6 6.87 ±1.1 6.34 ±1.3
Oleic 32.9 ±0.5 28.6 ± 1.2 27.2 ± 1.5 27.3 ±1.9 28.2 ±2.3
Linoleic 17.5 ± 1.0 16.1 ±0.9 19.8 ±2.8 21.6 ± 0.8 22.6 ± 2.1
Linolenic 1.34 ±0.0 1.33 ±0.1 2.73 ±0.5 3.27 ±0.3 3.4 ± 0.1
Arachidonic 4.58 ±0.4 6.68 ±0.9 3.7 ±0.8 2.86 ± 0.6 2.07 ±0.8
Docosahexaenoic 4.63 ±0.3 11.2 ± 2.1 7.78 ±0.9 6.75 ±1.9 3.47 ±0.6
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Figure 6. Percentage of docosahexaenoic acid (DHA) (% w/w of total lipid) 
in the egg yolk lipid class during embryonic development. Results are 
means of 4 replicates + S.E.M. Statistical analysis was performed on each 
consecutive day, between day 0 and day 10 and between day 10 and day 16.
dP<0.025, CP<0.01, aP<0.001. Cholesteryl ester (CE), triacylglycerol (TG),
free fatty acid (FFA), phospholipid (PL).
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3.2. INVESTIGATION OF PHOSPHOLIPASE A2 ACTIVITY DURING  
EMBRYONIC DEVELOPMENT.
An investigation o f PLA2 activity was carried out to establish the mechanism whereby 
DHA is transferred from the PL fraction to the FFA fraction in egg yolk and in the 
yolk sac membrane during development. The investigation was performed between 
day 10 and day 16 o f development, coinciding with the highest rate o f fatty acid 
transfer from the yolk to the yolk sac membrane. Results were expressed as pmole of 
fatty acid released per minute per mg o f tissue.
3.2.1. Phospholipase A2 activity in the yolk.
The PLA2 activity within the yolk is shown in Figure 7. At day 0 no PLA2 activity 
was detected in the yolk. A significant increase in PLA2 activity was found however 
on day 10. This activity remained high throughout the remaining developmental 
period.
3.2.2. Phospholipase A2 activity in the whole yolk sac membrane.
The PLA2 activity within the yolk sac membrane is shown in Figure 8. PLA2 activity 
was present at all stages examined, the activity was found to be low (6.80 ± 1.50 
pinole o f fatty acid release/min/mg o f protein) at day 10. The PLA2 activity then 
increased significantly from day 10 reaching a plateau on day 12 which was 
maintained to at least day 16.
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Day of development
Figure 7: Phospholipase A 2 activity (pm oles o f fatty acid release/ m in/ 
mg o f yolk protein) in the yolk during em bryogenesis. V alues are  
m eans + S .E .M ., o f at least five replicate sam ple. Statistical analysis
was perform ed by com parison to day 0. P<0.001.
Day of development
Figure 8: Phospholipase A2 activity (pm oles o f fatty acid release/ m in/ 
mg o f yolk sac m em brane protein) in the w hole yolk sac m em brane. 
V alues are m eans + S .E .M . o f at least 4 replicates. Statistical analysis
was perform ed by com parison to day 10. ' P<0.001.
3.3. ACTIVITIES OF SOME KEY ENZYMES INVOLVED IN LIPID 
METABOLISM IN YOLK SAC MEMBRANE AND LIVER.
An investigation o f the fatty acid metabolism o f the yolk sac membrane and liver 
during embryonic development has been undertaken. This study involved examining 
the activities o f the following key regulatory enzymes o f oxidation and acyl 
glycerolipid synthesis: carnitine palmitoyltransferase (CPT I), monoglycerol 
acyltransferase (MGAT), glycerolphosphate acyltransferase (GPAT) and 
diacylglycerol acyltransferase (DGAT).
3.3.1 CPT I activity in mitochondria of the yolk sac membrane during 
embryonic development and sensitivity to malonyl-CoA.
As shown on Figure 9 CPT I activity was determined between day 10 and day 18 of 
embryonic development. This period corresponded to the high rate o f lipid transfer 
from the yolk to the yolk sac membrane. Maximal CPT I activity was found on day 
12 o f development, 145 nmoles/min/mg o f protein. CPT I activity then significantly 
declined to 69 nmoles/min/mg o f protein on day 18. The sensitivity o f CPT I to 
inhibition by malonyl Co A is shown in Table 14. CPT I remain relatively insensitive 
to malonyl CoA throughout development. However there was a significant increase 
in its sensitivity to malonyl CoA on day 14.
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Figure 9: C PT I activity in the yolk sac m em brane m itochondria. 
V alues are expressed as m eans ± S .E .M . o f 4 replicates. Statistical 
analysis was carried out by com paring values o f day 12 and day 18,
aP<0.001.
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Table 14: Sensitiv ity  o f C P T  I to m alonyl-C oA  inhibition (m M  o f  
m alonyl C oA  for 50%  o f inhib ition). V alues are m eans ±  S .E .M . o f  
at least 3 replicates, c f  day 12 aP < 0.001 .
S e n s i t i v i t y  o f  CPT I  t o  M a l o n y l  C o A  I n h i b i t i o n
Days of development ID50 Malonyl CoA (mM )
10 18.56 ± 3 .05
12 26.67 ± 1.85
14 18.84 ± 0 .5 ia
16 28.96 + 6.51
18 24.79 ± 4.60
3.3.2. M GAT activity in yolk sac m em brane and liver du ring  em bryonic 
developm ent.
MGAT activity was present in both yolk sac membrane and liver. Results are 
presented on Figure 10 and 11. The activities are expressed as nmoles/min/mg of 
microsomal protein. The MGAT activity found in the yolk sac membrane was very 
high compared to that found in the liver (at day 12: 285 ± 13.2 and 25 ± 4.34 
nmols/min/mg o f protein, respectively). In the yolk sac membrane, the MGAT 
activity remained constant at around 248 nmoles/min/mg of microsomal protein 
throughout development. However at hatching the MGAT activity fell significantly to 
144 nmoles/min/mg of microsomal protein. In the liver, MGAT activity significantly 
increased to a peak on day 19 and decreased significantly at hatching.
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3.3.3. GPAT activity in the yolk sac membrane and the liver during embryonic
development.
Results are presented on Figure 12 and Table 15 and activities are expressed as 
nmoles/min/mg of either microsomal or mitochondrial protein. GPAT activity was 
associated with predominantly the microsomal fraction but also in the mitochondrial 
fraction in the yolk sac membrane. Microsomal GPAT was 10 fold greater than that 
found in the mitochondria. Microsomal GPAT activity peaked significantly on day 
12 at 26.6 nmoles/min/mg of protein and then steadily declined to an activity of 6.6 
nmoles/min/mg of protein at hatching. Similarly, GPAT activity was found in both 
microsomal and mitochondrial fractions in the liver. In comparison GPAT activity 
was very low compared to that found in the yolk sac membrane. A significant 
difference was found between microsomal GPAT activity on day 10 and that found 
on day 22. Mitochondrial activity remained low and did not change significantly 
during development.
3.3.4 DGAT activity in the yolk sac membrane and the liver during embryonic 
development.
DGAT activity (nmols/ min/ mg of microsomal protein) was found in both yolk sac 
membrane and liver tissues (Table 16 and Figure 15). In the yolk sac membrane, 
DGAT activity did not significantly change during embryonic development 
remaining at around 30 nmoles/min/mg of protein. However in the liver, DGAT 
activity was lower than found in the yolk sac membrane. Moreover an increase in 
DGAT activity was noted as development proceeded between day 14 and day 17, 
9.55 ± 2.55 and 22.4 ± 1.45 nmoles/min/mg of microsomal protein respectively.
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Figure 10: M G A T activity in the yolk sac m em brane m icrosom es. 
R esults are m eans o f 4 replicates ± S.E .M . Statistical analysis w as
carried out by com paring day 12 and day 22. P<0.001
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Figure 11: M G A T activity in the liver during em bryonic
developm ent. R esults are m eans o f 4 replicates ± S .E .M . Statistical 
analysis w as carried out by com paring values between day 12 to day
19 and day 19 to day 22. aP<0.001.
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Figure 12: G PA T  activity in the yolk sac m em brane during
em bryonic developm ent. R esults are m eans ± S .E .M . o f at least 4 
replicates. Statistical analysis was carrying out by com paring day 10
to day 12 and day 12 to day 22. eP<0.05, aP<0.001.
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Table 15: GPAT activity in the liver during embryonic development. 
Results are means ± S.E.M. of at least 4 replicates. Statistical 
analysis was performed, no significant differences were found.
Day of development 10 12 14 17 19 22
GPAT activity 
nmoles/min/mg of protein
Microsomes 2.5 10.3 2.610.1 3.010.3 3.1 + 0.4 2.5 10.3 3.610.3
M itochondria 1.410.3 0.5 10.1 0 .410.0  1.110.1 0 .610.0  1.210.1
Table 16: DGAT activity in the yolk sac membrane during
embryonic development. Results are means of 4 replicates ± S.E.M. 
Statistical analysis was performed, no significant differences were 
found.
Day of developm ent 10 12 14 17 19 22
DGAT activity 
(nmoles/min/mg o f protein)
Yolk 27.3 14.1 33.5 18.5 36.1 14.4  25.718.6 25.717.8 28.8 1
sac m em brane
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Figure 13: D G A T activity in the liver during em bryonic
developm ent. R esults are m eans o f 4 replicates ± S .E .M .. Statistical 
analysis was carried out. bP<G,005 c f  day 14
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3.4. FATTY ACID COM POSITION OF PLASMA LIPO PRO TEIN S FROM  
DEVELOPING CHICK EMBRYO.
Analysis of lipid class and lipid composition of blood lipoprotein species very low 
density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density 
lipoprotein (LDL), high density lipoprotein (HDL) were performed on day 14 and one 
day post hatch (day 22). Most of the plasma lipid is associated with the VLDL fraction 
on both days 14 and 22 (Table 17). In contrast, the IDL fraction accounts for only a 
small percentage of plasma lipid. On day 14 the LDL fraction is the second major 
contributor of plasma lipid, whereas the HDL fraction contributes only 8.5 %. In 
contrast, on day 22 the lipid associated with the LDL is reduced and a dramatic 
increase in the lipid contribution by HDL is noted.
Analysis of the lipid composition of day 14 lipoproteins shows a pattern of changes 
characteristic of lipoprotein metabolism. Such that the percentage of TG declines in 
accordance with LPL action, and there is a reciprocal increase in the percentage of PL. 
Interestingly the percentage of CE increased almost 5 fold from VLDL to HDL.
The lipid profile of day 22 lipoproteins was slightly different from that found on day 
14. Namely, the percentage of TG in the VLDL fraction was considerably lower, 
whereas the percentage of cholesteryl ester is 6 fold higher. The reciprocal changes in 
TG and PL are again noted, reflecting the action of LPL. The subtle differences 
suggest that the lipoproteins have a different origin. The day 14 lipoproteins possibly 
originated from the yolk sac membrane and the day 22 lipoproteins possibly originated 
from the liver.
Table 18 and 19 details the fatty acid composition of each lipid moiety in the different 
lipoproteins. In general there were no major differences in the fatty acid lipid 
composition on day 14 and day 22. Moreover, the fatty acid composition of the TG 
fraction was found to be similar in all lipoproteins, indicating a non-specific action of 
LPL. However, there is some evidence to suggest that LPL is less selective towards
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TG containing DHA, since a progressive enrichment o f this fatty acid was observed 
from VLDL through to HDL. DHA also made a significant contribution to the free 
fatty acid fraction. However, since this fraction is a minor part o f the total lipid the 
absolute amounts o f DHA would be necessarily small.
Table 17: Composition of lipoprotein (% w/w of lipid class) in
embryonic blood at day 14 and one day post hatch (day 22).
Days of development 14 22
VLDL IDL LDL HDL VLDL IDL LDL HDL
Lipoprotein 49 7.5 35 8.5 45 4 28 23
fraction (%, w/w of total lipid)
Lipid class (%, w/w of total lipid)
Phospholipid 16.6 23 22.5 35.4 13.9 17.8 23.2 38.2
Free fatty acid 0.71 3.1 0.69 2.55 0.6 6.8 0.9 2.3
Triacylglycerol 71.1 48.6 31.5 21.6 31.8 13.4 7.9 6.2
Cholesteryl ester 6.62 15.6 33.5 32.5 43.8 53.3 53.6 40.1
Free cholesterol 4.96 9.63 11.9 7.96 9.8 8.8 14.4 13.1
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Table 18:
Fatty add composition at day 14 (% w/w of total lipid) of lipid class in 
lipoprotein species: VLDL, (very low density lipoprotein), IDL 
(intermediate density lipoprotein), LDL (low density lipoprotein), HDL 
(high density lipoprotein). Analysis expressed results of plasma pooled 
from 20 embryos.
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Table 19:
Fatty acid composition at day 22 (% w/w of total lipid) of lipid class in 
lipoprotein species: VLDL, (very low density lipoprotein), IDL 
(intermediate density lipoprotein), LDL (low density lipoprotein), HDL 
(high density lipoprotein). Analysis expressed results of plasma pooled 
from 20 embryos.
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DISCUSSION
INTRODUCTION
An inadequate supply o f PUFAs may result in irreversible impairment o f brain and 
retinal function. A recent major conference on the role o f fatty acids in human health 
(Fourth International Congress on Essential Fatty acids and eicosanoids, Edinburgh, 
Scotland, July 1997) implicated PUFA as an important factor in a number o f illnesses 
such as alcoholism, schizophrenia, diabetes, ischaemic heart, disease and cancer. The 
formation o f neural tissues depends on a continuous supply o f essential fatty acids, n- 
3 and n-6 (linolenic acid and linoleic acid based respectively) at a critical period of 
development. In mammalian species during development, adequate amounts o f these 
essential fatty acids cross the placenta to meet the demands o f the foetus. In the avian 
it is very different, once the egg has been laid the embryo has to rely on pre-packaged 
nutrients to meet its development needs. Moreover, delivery o f essential fatty acids 
such as DHA to the developing embryo must be co-ordinated to meet the demands of 
various tissues (Noble, R.C. & Cocchi, M. 1989a).
The aim o f this study was to examine the metabolic processes underlying the fatty 
acid compositional changes occurring during avian embryo development (Maldjian, A. 
1996). The study encompassed three distinct stages o f PUFA transfer namely (1) 
uptake o f fatty acids from the yolk by the yolk sac membrane, (2) analysis o f the 
enzymatic machinery in fatty acid remodelling between different lipid moieties, and (3) 
delivery o f fatty acids to the developing embryo.
4.1. UPTAKE OF POLYUNSATURATED FATTY ACID FR O M  TH E  YOLK.
The transfer o f fatty acids from the yolk to the yolk sac membrane occurs by non 
specific phagocytosis. Yolk lipids are trapped by the apical microvilli and they are 
then enclosed within apical vesicles and appear within the yolk sac membrane (Noble, 
R.C. & Cocchi, M  1990). As discussed previously DHA uptake from the yolk does
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not follow the general pattern of other fatty acids (Noble, R.C. & Cocchi, M. 1990; 
Maldjian, A. et al 1995). Analysis of the yolk has also shown that there is a 
significant disappearance of DHA from the PE fraction during development and that 
this appears to be specific for DHA (Noble, R.C. & Moore, J.H. 1967b). This study 
lends support to these earlier findings. Analysis of the yolk lipid composition shows 
that the percentage of DHA associated with the free fatty acid fraction significantly 
increased and there is an associated decrease in the DHA associated with the PL 
fraction. As development proceeds there is a steady loss o f DHA from the FFA 
fraction and this correlates with the uptake of DHA by the yolk sac membrane 
(Maldjian, A. 1996).
4.1.1 Phospholipase A2.
As C20- C22 fatty acids are esterified at the second position of the glycerol backbone, it 
has been proposed therefore that the decrease in the percentage of DHA associated 
with the phospholipid fraction and its appearance in the free fatty acid fraction may be 
the result o f PLA2 action. In support of this concept, PLA2 activity was found in the 
yolk at day 10, although no activity was measured on day 0. This increase in enzyme 
activity in the yolk during development at a time when the percentage of DHA in the 
free fatty acid fraction increase's, supports a role of PLA2 in the uptake of DHA. DHA 
has been shown to be preferentially released as compared to other C22 fatty acids and 
mono- and di-unsaturated Ci8 fatty acids, from sheep erythrocyte phospholipids (Van 
Den Bosch, H. 1980). Detailed analysis of yolk PL has shown that it is the PE species 
that is preferentially hydrolysed. Although no substrate preference has been 
documented for PLA2 it is perhaps noteworthy that the PLA2 activity reported here was 
carried out using a probe esterified to PE. Therefore yolk PLA2 will hydrolyse PE, 
however no conclusions can be drawn with respect to its selectivity without analysing 
its activity against a PC substrate.
PLA2 has been shown to be secreted by exocrine glands such as the pancreas, or be 
membrane bound as is found in sheep erythrocytes (Van Den Bosch, H. 1990; Dennis,
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E.A. 1983). Therefore the yolk sac membrane was analysed for PLA2 activity as a 
probable source o f the yolk enzyme. Analysis o f the PLA2 activity in the yolk sac 
membrane was shown to be similar to that found in the yolk although the level o f 
activity found on day 10 was considerably lower. PLA2 activity in the yolk sac 
membrane increased to a plateau level at day 14. The PLA2 activity in the yolk was 
constant between day 10 and day 16. On the basis o f these results it is proposed that 
the yolk sac membrane may secrete PLA2 into the yolk at around day 10. However, 
in order to substantiate this a more detailed analysis o f the PLA2 species in the yolk 
and the yolk sac membrane is required. For instance, purification of the enzymes 
would enable a more detailed comparison.
In this study it was found that PLA2 was Ca2+ dependant. For PLA2 to have a 
physiological role in the mobilisation o f essential fatty acids there therefore must be an 
adequate Ca2+ concentration. It has been shown that the yolk Ca2+ concentration 
increases significantly at around day 10 (Johnston & Camar 1955), coincident with 
the reported increases in PLA2 activity. At this time it can be concluded that PLA2 
may play an important role in the uptake o f essential fatty acid from the yolk by the 
yolk sac membrane.
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4.2. M ETABOLISM  O F POLYUNSATURATED FATTY A CID IN THE 
Y O LK  SAC M EM BRANE.
Fatty acids required for the development o f the embryo are supplied by the yolk. The 
yolk provides synthetic maternal and a source o f energy for the developing embryo. 
The total energy requirements for embryogenesis are derived from the oxidation o f 
fatty acids. It has been found that some essential PUFA, namely DHA and AA, 
appear to be preserved and are not oxidised. A high percentage o f  the initial yolk 
content o f AA and DHA was recovered in the newly hatched chick, compared to the 
major Ci6 and Ci8 fatty acids (Maldjian, A. 1996). Alternatively, de novo synthesis o f 
these fatty acids is possible due to the existence of a desaturation/elongation system. 
De novo synthesis o f DHA is unlikely however due to the low level o f the substrate, 
linolenic acid. However de novo synthesis o f AA may occur due to  the presence of 
linoleic acid, the substrate. Within the yolk sac membrane it has been found that 
PUFAs are remodelled between lipid moieties, for example DHA is found associated 
with the PL fraction in the yolk but associated with the TG in the plasma. All these 
metabolic changes suggest a major role o f the yolk sac membrane in the successful 
co-ordination o f fatty acid transfer to the developing embryo. One aim o f this study 
was to investigate how PUFAs are transferred to the embryo without being oxidised 
for energy. The existence and activity o f rate limiting enzymes o f  the oxidative and 
esterification pathways were investigated to determine the possible metabolic fate of 
PUFAs and their possible regulation during development.
4.2.1. Oxidation pathw ay
The rate o f p-oxidation was determined by measuring the activity o f  the rate limiting 
enzyme carnitine palmitoyltransferase I (CPT I). The yolk sac membrane expressed 
considerably high activity o f CPT I compared to that found in other animals tissues, 
for example, liver CPT I activity in the starved refed rat was 44 nmoles/min/mg of 
protein (Granthan, B.D. & Zammit, V.A. 1986), and in the rat heart CPT I activity
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was 35 nmoles/min/mg o f protein. The metabolic processes taking place within the 
yolk sac membrane will place a high demand on energy provision therefore it is not 
surprising that CPT I activity is high to insure an adequate supply o f energy. CPT I 
activity declines from day 12 which presumably parallels the yolk sac membranes 
decreasing energy demands. Despite this high oxidative activity in the yolk sac 
membrane, major PUFAs are protected from oxidation. It may be that the substrate 
specificity o f yolk sac membrane CPT I allows selective retention o f PUFAs. In rat 
heart CPT I was shown to prefer palmitoyl-CoA compared to docosahexaenoyl-CoA 
(Nada, A.M., Abdel-Aleem, S. & Schulz, H. 1995). Moreover in the rat liver, the 
rate o f oxidation o f C20 fatty acid was lower than with other unsaturated fatty acid 
such as oleic acid, linoleic acid and a-linoleic acid. These differences were explained 
by the selective incorporation o f C20 into membrane phospholipids (Leyton, J., Drury, 
P.J. & Crawford, M.A. 1987). Inhibition by malonyl-CoA is known to be a 
mechanism by which mitochondrial oxidation o f long chain fatty acids can be 
regulated (Schulz, H. 1991). Yolk sac membrane CPT I was shown to be more 
sensitive to malonyl-CoA at day 14. This change takes place exactly at the time when 
CPT I activity decrease from 145 to 96 nmol/min/mg o f mitochondrial protein. This 
feature may have a major role on PUFA protection against oxidation, especially since 
the rate o f DHA uptake from the yolk is maximal at around this time.
4.2.2. Esterification pathw ays.
Fatty acid esterification is possible via acylation o f glycerol 3-phosphate or acylation 
of monoacylglycerol phosphate. Each pathway however ultimately results in the 
formation o f diacylglycerol which can then be acylated by DGAT to form 
triacylglycerol or diverted to phospholipid formation. The rate limiting enzymes for 
both the glycerol 3-phosphate and monoglycerol phosphate pathways were found in 
the yolk sac membrane, therefore fatty acid esterification by either route is 
metabolically feasible. Moreover the presence o f DGAT activity in the yolk sac 
membranes completes the TG synthetic pathway. Yolk sac membrane DGAT activity 
showed no fluctuation during development, the activity o f this tissue to synthesise
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triacylglycerol from diacylglycerol does not appear to be regulated at least at the 
enzyme level during development. The activity of yolk sac membrane DGAT must 
be sufficient to allow adequate acylation of diacylglycerol to supply the need for TG 
for lipoprotein synthesis.
GPAT and MGAT were present at all stages of development in the yolk sac 
membrane. The MGAT activity showed no fluctuation during development and was 
at least 10 fold greater than that found for GPAT activity, suggesting that in this 
tissue the MGAT athway may be of greater importance for glycerolipid synthesis that 
the GPAT pathway. However, it is noteworthy that the MGAT pathway does not 
appear to be regulated at least at the enzyme level. As suggested previously, the 
MGAT pathway may be a way of selectively retaining essential fatty acids (Tian Xia, 
et al 1993). MGAT used monoacylglycerol as its substrate with the fatty acid 
esterified at the 2 position. DHA is present in the second position of PE. If the 
MGAT pathway is the mechanism whereby DHA is selectively preserved then the PE 
containing DHA must first be acted on by a PL A] and then presumably a 
phospholipase C, to provide a suitable substrate. The yolk sac membrane PLA2 
suggests an alternative mechanism. The activity of yolk sac membrane GPAT was 
found to be regulated during development with a peak at day 12. Therefore this may 
be an important route for PUFA reesterification if  the PUFA is in the form of a free 
fatty acid, as suggested in the case of DHA. Maximum rates of DHA uptake from 
the yolk occurred at around day 12, if DHA is taken up as a free fatty acid, the GPAT 
pathway may be the preferred esterification route. Moreover at this time CPT I 
activity was found to decrease which may contribute to free fatty acids being directed 
towards esterification and away from oxidation. However, as discussed earlier no 
information was obtained with respect to substrate specificity of either CPT I or 
GPAT and this would obviously dictate the fate o f certain fatty acids.
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Diagram 5:
Suggested mechanism by which DHA present in the yolk is transferred 
into triacylglycerol in the yolk sac membrane. Docosahexaenoic acid 
(DHA); malonyl-CoA (M-CoA); carnitine palmitoyltransferase I (CPT I); 
glycerol acyltransferase (GPAT); diacylglycerol acyltransferase (DGAT); 
free fatty acid (FFA); phospholipase A2 (PLA2 ).
Yolk
Phospholipase A2: action; release of DHA as FFA.
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4.3. DELIVERY O F POLYUNSATURATED FATTY ACID TO THE 
TISSUES.
Clearly one o f the functions o f the yolk sac membrane is to supply the embryo with 
adequate levels o f C20 and C22 polyunsaturated fatty acids, since deficiencies in the 
supply o f DHA during the relevant period o f development are associated with 
irreversible impairment o f neural development (Neuringer, M., Anderson, G.J. & 
Connor, W.E. 1988). With respect to the supply o f DHA, the transfer o f this fatty 
acid is possible by the simultaneous action o f PLA2 in the yolk and an esterification 
system able to divert essential fatty acid from oxidation. The delivery o f PUFAs to 
the embryo was studied by carrying out a lipoprotein analysis at day 14 and day 22.
4.3.1. Adipose tissue and lipoprotein lipase activity.
A constant provision o f DHA is essential for the normal development o f the brain, the 
results o f a detailed study (Lin, D.S., Connor, W.E. & Anderson, G.J. 1991) have 
indicated that the levels o f DHA do not respond proportionally to major changes in 
the yolk content o f this fatty acid. These authors suggested that the brain PL may 
have an optimal fatty acid composition that is compatible with normal functional 
development. Furthermore, it was suggested that to maintain this optimal 
composition, the brain may possess the capability to regulate its incorporation of 
PUFAs in response to changes in provision from the yolk. But having established that 
lipoprotein lipase activity is not expressed by the brain o f the chick embryo, PUFA 
delivery must occur via an alternative mechanism and if such mechanism is mediated 
at the level o f PUFA transport from the yolk to the brain, the adipose tissue seems to 
have an important role. High lipoprotein lipase activity is expressed by adipose tissue 
and the fatty acids released by this enzyme are taken up by the adipose tissue for 
storage (Speake, B.K. et al 1993). In accordance with LPL action the percentage o f 
TG in the metabolised lipoproteins declines with a reciprocal increase in the 
percentage o f PL. However an increased percentage o f DHA associated with TG
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within the resulting lipoprotein particles was found. This is in accordance to the study 
of Melin et al (1991) who showed TG species containing C20-C22 PUFA exhibited a 
degree of resistance to LPL action. However, the high LPL activity in the adipose 
tissue resulted in some incorporation of DHA and AA (Speake, B.K. et al 1991). In 
contrast to other major fatty acids present, in vitro studies have shown that DHA and 
AA are selectively mobilised from adipose tissue at the end of embryonic development 
(Speake, B.K. et al 1997). Most of the fatty acids have been transferred from the yolk 
complex by this time, importantly the transfer of DHA is complete by day 19. The 
functional significance of this selective mobilisation and release of DHA from adipose 
tissue could be to constantly support the embryonic development of neural tissues 
(Noble, R.C. & Speake, B.K. 1997). The PUFA stored within adipose tissue may 
represent a reserve which allows a steady supply o f essential PUFA's to the developing 
tissues at critical development points. It has been suggested that free fatty acid bound 
to albumin (or a-fetoprotein) is a preferred source of PUFA's for the brain (Anderson, 
G.J. et al 1988). Therefore release of DHA from adipose tissue as a free fatty acid 
could be a possible mechanism for delivery to neural tissues. Alternatively, free fatty 
acid released by the adipose tissue may be taken up by the liver which would then co­
ordinate the supply to the developing tissues.
4.3.2. Role of the liver
Lipoprotein analysis showed that following the action of LPL the resulting 
lipoproteins were enriched in DHA within the TG faction (Table 18). This DHA 
could then be released by further lipase action, although not LPL, or the lipoprotein 
may be removed by the liver. However, our results do not support further hydrolysis 
since there was a progressive enrichment in the percentage of DHA associated with 
the TG in the metabolised lipoproteins. Previously it has been shown that liver 
DHA is initially associated with TG fraction at around day 14 (Maldjian, A. 1996) 
which suggests that the DHA enriched TG is cleared by the liver. As development 
proceeded this DHA was found to be gradually transferred from TG to PL (Nobel, 
R.C. & Cocchi, M. 1990). As discussed earlier the MGAT pathway has been
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suggested to be responsible for protecting PUFAs from oxidation. The increase in 
liver MG AT activity up to day 19 o f development suggests a possible role for this 
enzyme in the DHA remodelling between the lipid moieties. Moreover the low GPAT 
activity compared to the MGAT activity (at day 19, 2.5 ± 0.3 and 70 ± 2.7 nmoles/ 
min/ mg o f microsomal protein respectively) suggests that this acylation pathway is 
less important. However the substrate specificity o f each enzyme is not known, which 
would o f course have important ramifications.
The hepatic accumulation o f CE during embryonic development derives from the 
uptake o f cholesterol rich lipoproteins secreted from the yolk sac membrane as well as 
the inefficiency o f the embryonic liver in disposing o f this excess material (Noble, 
R.C. & Cocchi, M  1990; Speake, B.K. et a l  1993). A proportion o f the CE may 
also be hydrolysed to free cholesterol through lysosomal fusion. Free cholesterol can 
then be incorporated into the liver cell membrane, or excreted as bile. Alternatively, 
the cholesterol can be esterified back to CE by the action o f AC AT enzyme. Tarugi 
et al (1994) showed that the depletion o f hepatic CE was coincident with an increased 
in hepatic synthesis o f apoB and apoA-I and suggested that the liver syntheses and 
presumably secretes lipoproteins enriched in CE. The significant increase in hepatic 
DGAT activity from day 12 to day 19 (25 ± 4.3 and 70 ± 2.7 nmoles/min/mg o f 
microsomal protein respectively) supports this view, demonstrating that the liver has 
the capacity for TG synthesis necessary for lipoprotein assembly. Moreover, analysis 
o f plasma lipoproteins at day 22 showed that the percentage o f CE associated with 
the VLDL fraction was considerably higher than that found on day 14. Secretion o f 
lipoproteins from the liver with DHA associated with the PL fraction may be a 
possible route o f DHA delivery to the brain (Scott, B.K. & Bazan, N.G. 1989). 
Analysis o f lipoprotein at day 22 showed that DHA was ended associated with the PL 
fraction. Alternatively, it has been proposed that lyso PC is the preferred substrate for 
brain uptake o f DHA (Thies, F. et a l 1994). Further work is however necessary to 
clarify this possibility.
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4.3.3. Delivery to the brain
The phospholipids o f the brain and retina of the embryo are especially enriched in 
DHA. In this system, DHA delivery to the brain could be mediated via the adipose 
tissue regulating delivery as the free fatty acid, alternatively the supply o f DHA to the 
brain may be controlled by the liver. DHA within the liver as been shown to be 
remodelled from TG to PL and this DHA could then be secreted associated with 
VLDL particles or secreted as lysoPC. (See Diagram 6)
Clearly more study is needed to identify the origin o f the isolated lipoproteins at each 
day o f development, which could have come from either the liver or the yolk sac 
membrane. The mechanism by which DHA is remodelled between lipid moieties 
requires further detailed analysis. The incorporation o f radioactively labelled fatty 
acids in the yolk at early stage seems to be a next step on polyunsaturated fatty acid 
investigation.
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